Publicaties

ARC Publications 2018

 

 

 

June 2018

 

Boers M.

Designing effective graphs to get your message across.

Ann Rheum Dis. 2018 Jun;77(6):833-839. doi: 10.1136/annrheumdis-2018-213396. Review. PMID:29748338

 

May 2018

 

Biesbroek PS, Heslinga SC, van de Ven PM, Peters MJL, Amier RP, Konings TC, Maroules CD, Ayers C, Joshi PH, van der Horst-Bruinsma IE, van Halm VP, van Rossum AC, Nurmohamed MT, Nijveldt R.

Assessment of aortic stiffness in patients with ankylosing spondylitis using cardiovascular magnetic resonance.

Clin Rheumatol. 2018 May 12. doi: 10.1007/s10067-018-4135-x. [Epub ahead of print] PMID:29754182

 

Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE.

Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.

Curr Rheumatol Rep. 2018 May 12;20(6):35. doi: 10.1007/s11926-018-0744-2. Review. PMID:29754330

 

van Meerbeeck JP, Jansen G, Giovannetti E, Peters GJ.

Aminopeptidase antibodies in mesothelioma: new wine deserves new sacks.

Eur Respir J. 2018 May 24;51(5). pii: 1800817. doi: 10.1183/13993003.00817-2018. Print 2018 May. No abstract available. PMID:29794125

 

Taylor JC, Bongartz T, Massey J, Mifsud B, Spiliopoulou A, Scott IC, Wang J, Morgan M, Plant D, Colombo M, Orchard P, Twigg S, McInnes IB, Porter D, Freeston JE, Nam JL, Cordell HJ, Isaacs JD, Strathdee JL, Arnett D, de Hair MJH, Tak PP, Aslibekyan S, van Vollenhoven RF, Padyukov L, Bridges SL, Pitzalis C, Cope AP, Verstappen SMM, Emery P, Barnes MR, Agakov F, McKeigue P, Mushiroda T, Kubo M, Weinshilboum R, Barton A, Morgan AW, Barrett JH; MATURA; and PAMERA; Consortia.

Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients.

Pharmacogenomics J. 2018 May 25. doi: 10.1038/s41397-018-0025-5. [Epub ahead of print] Review. PMID:29795407

 

Chandrupatla DMSH, Molthoff CFM, Ritsema WIGR, Vos R, Elshof E, Matsuyama T, Low PS, Musters RJP, Hammond A, Windhorst AD, Lammertsma AA, van der Laken CJ, Brands R, Jansen G.

Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexate.

Translational Res. 2018 May 17. pii: S1931-5244(18)30055-0. doi: 10.1016/j.trsl.2018.04.001. [Epub ahead of print] PMID:29802817

 

Jiemy WF, Heeringa P, Kamps JAAM, van der Laken CJ, Slart RHJA, Brouwer E.

Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of macrophages in large vessel vasculitis: Current status and future prospects.

Autoimmun Rev. 2018 May 3. pii: S1568-9972(18)30115-0. doi: 10.1016/j.autrev.2018.02.006. [Epub ahead of print] Review. PMID:29729443

 

Tran-Duy A, Ghiti Moghadam M, Oude Voshaar MAH, Vonkeman HE, Boonen A, Clarke P, McColl G, Ten Klooster PM, Zijlstra TR, Lems WF, Riyazi N, Griep EN, Hazes JMW, Landewé R, Bernelot Moens HJ, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

An Economic Evaluation of Stopping versus Continuing TNF-Inhibitor Treatment in Rheumatoid Arthritis Patients in Remission or Low Disease Activity: results from the POET randomized trial.

Arthritis Rheumatol. 2018 May 9. doi: 10.1002/art.40546. [Epub ahead of print] PMID:29745059

 

Kraal LJN, Nijland ML, Germar KL, Baeten DLP, Ten Berge IJM, Fehres CM.

Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients.

PLoS One. 2018 May 10;13(5):e0197219. doi: 10.1371/journal.pone.0197219. eCollection 2018. PMID:29746558

 

Dahmen R, Siemonsma PC, Monteiro S, Norman GR, Boers M, Lankhorst GJ, Roorda LD.

Evaluation of the wear-and-tear scale for therapeutic footwear, results of a generalizability study.

J Rehabil Med. 2018 May 16. doi: 10.2340/16501977-2339. [Epub ahead of print] PMID:29767226

 

van Mens LJJ, van de Sande MGH, van Kuijk AWR, Baeten DLP, Coates LC.

Response to: ‘To DAPSA or not to DAPSA? That is not the question’ by Schoels et al.

van Mens LJJ, van de Sande MGH, van Kuijk AWR, Baeten DLP, Coates LC.

Ann Rheum Dis. 2018 May 18. pii: annrheumdis-2018-213618. doi: 10.1136/annrheumdis-2018-213618. [Epub ahead of print] No abstract available. PMID:29776975

 

van Tubergen A, Gulpen A, Landewé R, Boonen A.

Are globals for health, well-being and quality of life interchangeable? A mixed methods study in ankylosing spondylitis patients and controls.

Rheumatology (Oxford). 2018 May 19. doi: 10.1093/rheumatology/key129. [Epub ahead of print] PMID:29788458

 

Ghiti Moghadam M, Lamers-Karnebeek FBG, Vonkeman HE, Ten Klooster PM, Tekstra J, Schilder AM, Visser H, Sasso EH, Chernoff D, Lems WF, van Schaardenburg DJ, Landewe R, Bernelot Moens HJ, Radstake TRDJ, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET Collaboration.

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment.

PLoS One. 2018 May 23;13(5):e0192425. doi: 10.1371/journal.pone.0192425. eCollection 2018. PMID:29791439

 

Chiarotto A, Terwee CB, Kamper SJ, Boers M, Ostelo RW.

Evidence on the measurement properties of health-related quality of life instruments is largely missing in patients with low back pain, a systematic review.

J Clin Epidemiol. 2018 May 21. pii: S0895-4356(17)31316-1. doi: 10.1016/j.jclinepi.2018.05.006. [Epub ahead of print] Review. PMID:29793009

 

Baniaamam M, Paulus WJ, Blanken AB, Nurmohamed MT.

The effect of biological DMARDs on the risk of congestive heart failure in rheumatoid arthritis: a systematic review.

Expert Opin Biol Ther. 2018 May;18(5):585-594. doi: 10.1080/14712598.2018.1462794. Epub 2018 Apr 23. PMID:29623726

 

Landewé RBM, van der Heijde D.

“Big Data” in Rheumatology: Intelligent Data Modeling Improves the Quality of Imaging Data.

Rheum Dis Clin North Am. 2018 May;44(2):307-315. doi: 10.1016/j.rdc.2018.01.007. Review. PMID:29622297

 

April 2018

 

Doria A, Stohl W, Schwarting A, Okada M, Scheinberg M, van Vollenhoven R, Hammer AE, Groark J, Bass D, Fox NL, Roth D, Gordon D.

Efficacy and safety of subcutaneous belimumab in anti-dsDNA-positive, hypocomplementemic patients with systemic lupus erythematosus.

Arthritis Rheumatol. 2018 Apr 18. doi: 10.1002/art.40511. [Epub ahead of print] PMID:29671280

 

Boers M, Singh JA, Cofield SS, Bridges SL Jr, Moreland LW, O’Dell JR, Wu H, Leatherman S, Curtis JR.

A novel method to combine assessment of benefit and harm: OMERACT 3×3 methodology applied to two active comparator trials.

Arthritis Care Res (Hoboken). 2018 Apr 25. doi: 10.1002/acr.23590. [Epub ahead of print] PMID:29691998

 

Van Vollenhoven RF, Lee EB, Fallon L, Zwillich SH, Wilkinson B, Chapman D, Demasi R, Keystone E.

Tofacitinib in Rheumatoid Arthritis: Lack of Early Change in Disease Activity Predicts a Low Probability of Achieving Low Disease Activity at Month 6.

Arthritis Care Res (Hoboken). 2018 Apr 26. doi: 10.1002/acr.23585. [Epub ahead of print] PMID:29696833

 

van de Sande MGH, van Vollenhoven RF.

Evolution of clinical trials for rheumatoid arthritis and spondyloarthritis.

Curr Opin Rheumatol. 2018 Apr 24. doi: 10.1097/BOR.0000000000000516. [Epub ahead of print] PMID:29697434

 

Saag KG, Wagman RB, Geusens P, Adachi JD, Messina OD, Emkey R, Chapurlat R, Wang A, Pannacciulli N, Lems WF.

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study.

Lancet Diabetes Endocrinol. 2018 Apr 6. pii: S2213-8587(18)30075-5. doi: 10.1016/S2213-8587(18)30075-5. [Epub ahead of print] PMID:29631782

 

Rusman T, Ten Wolde S, Euser SM, van der Ploeg T, van Hall O, van der Horst-Bruinsma IE.

Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice.

Int J Rheum Dis. 2018 Apr;21(4):836-842. doi: 10.1111/1756-185X.13271. PMID:29611349

 

van Lunteren M, Scharloo M, Ez-Zaitouni Z, de Koning A, Landewé R, Pt CF, Ramonda R, Kaptein AA, van Gaalen FA, van der Heijde D.

The impact of illness perceptions and coping on the association between back pain and health outcomes in patients suspected of axial spondyloarthritis: data from the SPACE cohort.

Arthritis Care Res (Hoboken). 2018 Apr 2. doi: 10.1002/acr.23566. [Epub ahead of print] PMID:29609197

 

 

March 2018

 

Visser A, Doorenspleet ME, de Vries N, Spijkervet FKL, Vissink A, Bende RJ, Bootsma H, Kroese FGM, Bos NA.

Acquisition of N-Glycosylation Sites in Immunoglobulin Heavy Chain Genes During Local Expansion in Parotid Salivary Glands of Primary Sjögren Patients.

Front Immunol. 2018 Mar 12;9:491. doi: 10.3389/fimmu.2018.00491. eCollection 2018. PMID:29662487

 

Maharaj AB, Naidoo P, Ghazi T, Abdul NS, Dhani S, Docrat TF, Ramkaran P, Tak PP, de Vries N, Chuturgoon AA.

MiR-146a G/C rs2910164 variation in South African Indian and Caucasian patients with psoriatic arthritis.

BMC Med Genet. 2018 Mar 27;19(1):48. doi: 10.1186/s12881-018-0565-1. PMID:29587639

 

Ez-Zaitouni Z, Landewé R, van Lunteren M, Bakker PA, Fagerli KM, Ramonda R, Jacobsson LTH, van der Heijde D, van Gaalen FA.

Imaging of the sacroiliac joints is important for diagnosing early axial spondyloarthritis but not all-decisive.

Rheumatology (Oxford). 2018 Mar 20. doi: 10.1093/rheumatology/key035. [Epub ahead of print] PMID:29579265

 

Strik AS, van de Vrie W, Bloemsaat-Minekus JPJ, Nurmohamed M, Bossuyt PJJ, Bodelier A, Rispens T, van Megen YJB, D’Haens GR; SECURE study group.

Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial.

Lancet Gastroenterol Hepatol. 2018 Mar 29. pii: S2468-1253(18)30082-7. doi: 10.1016/S2468-1253(18)30082-7. [Epub ahead of print] PMID:29606564

 

Kelly A, Tong A, Tymms K, March L, Craig JC, De Vera M, Evans V, Hassett G, Toupin-April K, van den Bemt B, Teixeira-Pinto A, Alten R, Bartlett SJ, Campbell W, Dawson T, Gill M, Hebing R, Meara A, Nieuwlaat R, Shaw Y, Singh JA, Suarez-Almazor M, Sumpton D, Wong P, Christensen R, Beaton D, de Wit M, Tugwell P; OMERACT-Adherence Group.

Outcome Measures in Rheumatology – Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.

Trials. 2018 Mar 27;19(1):204. doi: 10.1186/s13063-018-2565-z. PMID:29587864

 

Turk SA, van Schaardenburg D, Boers M, de Boer S, Fokker C, Lems WF, Nurmohamed MT.

An unfavorable body composition is common in early arthritis patients: A case control study.

PLoS One. 2018 Mar 22;13(3):e0193377. doi: 10.1371/journal.pone.0193377. eCollection 2018. PMID:29565986

 

van Tuyl LHD, Boers M.

The controversy of using PGA to define remission in RA.

Nat Rev Rheumatol. 2018 Mar 21;14(4):245. doi: 10.1038/nrrheum.2018.36. No abstract available. PMID:29559715

 

Roos E, Hubers LM, Coelen RJS, Doorenspleet ME, de Vries N, Verheij J, Beuers U, van Gulik TM.
IgG4-Associated Cholangitis in Patients Resected for Presumed Perihilar Cholangiocarcinoma: a 30-Year Tertiary Care Experience.

Am J Gastroenterol. 2018 Mar 16. doi: 10.1038/s41395-018-0036-5. [Epub ahead of print] PMID:29549357

 

van Lunteren M, Ez-Zaitouni Z, de Koning A, Dagfinrud H, Ramonda R, Jacobsson L, Landewé R, van der Heijde D, van Gaalen FA.

In Early Axial Spondyloarthritis, Increasing Disease Activity Is Associated with Worsening of Health-related Quality of Life over Time.

J Rheumatol. 2018 Mar 15. pii: jrheum.170796. doi: 10.3899/jrheum.170796. [Epub ahead of print] PMID:29545448

 

van der Heijde D, Daikh DI, Betteridge N, Burmester GR, Hassett AL, Matteson EL, van Vollenhoven R, Lakhanpal S.

Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).

Ann Rheum Dis. 2018 Mar 10. pii: annrheumdis-2017-212565. doi: 10.1136/annrheumdis-2017-212565. [Epub ahead of print] Review.PMID:29525777

 

van Vollenhoven RF, L’Ami M, Wolbink G.

[Personalised medicine in rheumatology].

Tijdschr Psychiatr. 2018;60(3):146-150. Dutch. PMID:29521400

 

de Winter J, de Hooge M, van de Sande M, de Jong H, van Hoeven L, de Koning A, Berg IJ, Ramonda R, Baeten D, van der Heijde D, Weel A, Landewé R.

An ASAS-Positive MRI of the Sacroiliac Joints can also Occur in Healthy Individuals, Runners and Women with Postpartum Back Pain.

Arthritis Rheumatol. 2018 Mar 7. doi: 10.1002/art.40475. [Epub ahead of print]. PMID:29513924

 

Lloyd KA, Steen J, Amara K, Titcombe PJ, Israelsson L, Lundström SL, Zhou D, Zubarev RA, Reed E, Piccoli L, Gabay C, Lanzavecchia A, Baeten D, Lundberg K, Mueller DL, Klareskog L, Malmström V, Grönwall C.

Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: implications for B-cell selection.

Eur J Immunol. 2018 Mar 7. doi: 10.1002/eji.201747446. [Epub ahead of print] PMID:29512823

 

Boot CRL, de Wind A, van Vilsteren M, van der Beek AJ, van Schaardenburg D, Anema JR.

One-year Predictors of Presenteeism in Workers with Rheumatoid Arthritis: Disease-related Factors and Characteristics of General Health and Work.

J Rheumatol. 2018 Mar 1. pii: jrheum.170586. doi: 10.3899/jrheum.170586. [Epub ahead of print] PMID:29496893

 

Broos CE, Koth LL, van Nimwegen M, In ’t Veen JCCM, Paulissen SMJ, van Hamburg JP, Annema JT, Heller-Baan R, Kleinjan A, Hoogsteden HC, Wijsenbeek MS, Hendriks RW, van den Blink B, Kool M.

Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes.

Eur Respir J. 2018 Mar 1;51(3). pii: 1701124. doi: 10.1183/13993003.01124-2017. Print 2018 Mar.

PMID:29449421

 

Maracle CX, Agca R, Helder B, Meeuwsen JAL, Niessen HWM, Biessen EAL, de Winther MPJ, de Jager SCA, Nurmohamed MT, Tas SW.

Noncanonical NF-κB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.

Atherosclerosis. 2018 Mar;270:33-41. doi: 10.1016/j.atherosclerosis.2018.01.032. Epub 2018 Jan 31. PMID:29407886

 

 

February 2018

Chandrupatla DMSH, Jansen G, Mantel E, Low PS, Matsuyama T, Musters RP, Windhorst AD, Lammertsma AA, Molthoff CFM, van der Laken CJ.

Imaging and Methotrexate Response Monitoring of Systemic Inflammation in Arthritic Rats Employing the Macrophage PET Tracer [18F]Fluoro-PEG-Folate.

Contrast Media Mol Imaging. 2018 Feb 21;2018:8092781. doi: 10.1155/2018/8092781. eCollection 2018. PMID:29681783

 

Britsemmer K, van Schaardenburg D, Boers M, De Cock D, Verschueren P, Radner H, Smolen JS, van Tuyl L.

Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.

Clin Exp Rheumatol. 2018 Feb 26. [Epub ahead of print] PMID:29533752

 

Hansen IS, Krabbendam L, Bernink JH, Loayza-Puch F, Hoepel W, van Burgsteden JA, Kuijper EC, Buskens CJ, Bemelman WA, Zaat SAJ, Agami R, Vidarsson G, van den Brink GR, de Jong EC, Wildenberg ME, Baeten DLP, Everts B, den Dunnen J.

FcαRI co-stimulation converts human intestinal CD103dendritic cells into pro-inflammatory cells through glycolytic reprogramming.

Nat Commun. 2018 Feb 28;9(1):863. doi: 10.1038/s41467-018-03318-5. PMID:29491406

 

Hähnlein JS, Nadafi R, de Jong T, Ramwadhdoebe TH, Semmelink JF, Maijer KI, Zijlstra IA, Maas M, Gerlag DM, Geijtenbeek TBH, Tak PP, Mebius RE, van Baarsen LGM.

Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritis.

Arthritis Res Ther. 2018 Feb 26;20(1):35. doi: 10.1186/s13075-018-1529-8.

PMID:29482663

 

Falkenburg WJJ, Kempers AC, Dekkers G, Ooijevaar-de Heer P, Bentlage AEH, Vidarsson G, van Schaardenburg D, Toes REM, Scherer HU, Rispens T.

Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.

Rheumatology (Oxford). 2018 Feb 21. doi: 10.1093/rheumatology/key056. [Epub ahead of print] No abstract available.PMID:29481646

 

Lim J, van Royen-Kerkhof A, Jonkers RE, Starink MV, Voskuyl AE, van der Kooi AJ.

[Myositis: more than a muscle disease].

Ned Tijdschr Geneeskd. 2018;162(0):D2312. Dutch. PMID:29473539

 

Tang MW, Malvar Fernández B, Newsom SP, van Buul JD, Radstake TRDJ, Baeten DL, Tak PP, Reedquist KA, García S.

Class 3 semaphorins modulate the invasive capacity of rheumatoid arthritis fibroblast-like synoviocytes.

Rheumatology (Oxford). 2018 Feb 19. doi: 10.1093/rheumatology/kex511. [Epub ahead of print] PMID:29471421

 

Loef M, Kroon FPB, Bergstra SA, van der Pol JA, Lems WF, Kerstens PJSM, Allaart CF, Kloppenburg M.

TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.

Rheumatology (Oxford). 2018 Feb 19. doi: 10.1093/rheumatology/key016. [Epub ahead of print] PMID:29471377

 

Hebeisen M, Neuenschwander R, Scherer A, Exer P, Weber U, Tamborrini G, Micheroli R, Wildi LM, Zufferey P, Nissen MJ, Villiger PM, Bernhard J, Finckh A, van der Horst-Bruinsma IE, Sieper J, Landewé R, van der Heijde D, Ciurea A; rheumatologists of the Swiss Clinical Quality Management Program.
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort.

J Rheumatol. 2018 Feb 15. pii: jrheum.170166. doi: 10.3899/jrheum.170166. [Epub ahead of print] PMID:29449504

 

Oerlemans R, Berkers CR, Assaraf YG, Scheffer GL, Peters GJ, Verbrugge SE, Cloos J, Slootstra J, Meloen RH, Shoemaker RH, Dijkmans BAC, Scheper RJ, Ovaa H, Jansen G.

Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide.

Invest New Drugs. 2018 Feb 14. doi: 10.1007/s10637-018-0569-x. [Epub ahead of print] PMID:29442210

 

Falkenburg WJJ, von Richthofen HJ, Koers J, Weykamp C, Schreurs MWJ, Bakker-Jonges LE, Haagen IA, Lems WF, Hamann D, van Schaardenburg D, Rispens T.

Clinically relevant discrepancies between different rheumatoid factor assays.

Clin Chem Lab Med. 2018 Feb 10. pii: /j/cclm.ahead-of-print/cclm-2017-0988/cclm-2017-0988.xml. doi: 10.1515/cclm-2017-0988. [Epub ahead of print] PMID:29427550

 

Bruijnen STG, Verweij NJF, van Duivenvoorde LM, Bravenboer N, Baeten DLP, van Denderen CJ, van der Horst-Bruinsma IE, Voskuyl AE, Custers M, van de Ven PM, Bot JCJ, Boden BJH, Lammertsma AA, Hoekstra OSH, Raijmakers PGHM, van der Laken CJ.

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.

Rheumatology (Oxford). 2018 Feb 3. doi: 10.1093/rheumatology/key034. [Epub ahead of print] No abstract available.PMID:29415219

 

van Beers-Tas MH, Stuiver MM, de Koning MHMT, van de Stadt LA, Geskus RB, van Schaardenburg D.

Can an increase in autoantibody levels predict arthritis in arthralgia patients?

Rheumatology (Oxford). 2018 Feb 1. doi: 10.1093/rheumatology/kex506. [Epub ahead of print] No abstract available. PMID:29401313

 

Roeten MSF, Cloos J, Jansen G.

Positioning of proteasome inhibitors in therapy of solid malignancies.

Cancer Chemother Pharmacol. 2018 Feb;81(2):227-243. doi: 10.1007/s00280-017-3489-0. Epub 2017 Nov 28. Review. PMID:29184971

 

Falkenburg WJJ, van Schaardenburg D.

Evolution of autoantibody responses in individuals at risk of rheumatoid arthritis.

Best Pract Res Clin Rheumatol. 2017 Feb;31(1):42-52. doi: 10.1016/j.berh.2017.07.005. Epub 2017 Aug 24. Review. PMID: 29221597

 

January 2018

Parodis I, Söder F, Faustini F, Kasza Z, Samuelsson I, Zickert A, Svenungsson E, van Vollenhoven RF, Malmström V, Wermeling F, Gunnarsson I.

Rituximab-mediated late-onset neutropenia in systemic lupus erythematosus – distinct roles of BAFF and APRIL.

Lupus. 2018 Jan 1:961203318777116. doi: 10.1177/0961203318777116. [Epub ahead of print] PMID:29783918

Hähnlein JS, Ramwadhdoebe TH, Semmelink JF, Choi IY, Berger FH, Maas M, Gerlag DM, Tak PP, Geijtenbeek TBH, van Baarsen LGM.

Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering.

Sci Rep. 2018 Jan 29;8(1):1736. doi: 10.1038/s41598-018-19951-5. PMID: 29379035

Hartman L, Rasch LA, Klausch T, Bijlsma HWJ, Christensen R, Smulders YM, Ralston SH, Buttgereit F, Cutolo M, Da Silva JAP, Opris D, Rovenský J, Szamosi S, Middelink LM, Lems WF, Boers M.

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.

Trials. 2018 Jan 25;19(1):67. doi: 10.1186/s13063-017-2396-3. PMID: 29370811

Boone NW, Liu L, Romberg-Camps MJ, Duijsens L, Houwen C, van der Kuy PHM, Janknegt R, Peeters R, Landewé RBM, Winkens B, van Bodegraven AA.

The nocebo effect challenges the non-medical infliximab switch in practice.

Eur J Clin Pharmacol. 2018 Jan 24. doi: 10.1007/s00228-018-2418-4. [Epub ahead of print] PMID: 29368188

Barturen G, Beretta L, Cervera R, Van Vollenhoven R, Alarcón-Riquelme ME.

Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Nat Rev Rheumatol. 2018 Jan 24;14(2):75-93. doi: 10.1038/nrrheum.2017.220. Review. PMID: 29362467

Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Buyon J, Isenberg DA, Rahman A, Ginzler EM, Petri M, Dooley MA, Fortin P, Gladman DD, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Sanchez-Guerrero J, Bruce IN.

Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort.

Rheumatology (Oxford). 2018 Jan 18. doi: 10.1093/rheumatology/kex444. [Epub ahead of print] PMID: 29361147

van Vollenhoven RF, Keystone EC, Strand V, Pacheco-Tena C, Vencovský J, Behrens F, Racewicz A, Zipp D, Rharbaoui F, Wolter R, Knierim L, Schmeidl R, Zhou X, Aigner S, Dälken B, Wartenberg-Demand A; TREAT2b study team.

Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.

Ann Rheum Dis. 2018 Jan 17. pii: annrheumdis-2017-212478. doi: 10.1136/annrheumdis-2017-212478. [Epub ahead of print] PMID:29343509

Chiarotto A, Boers M, Deyo RA, Buchbinder R, Corbin TP, Costa LOP, Foster NE, Grotle M, Koes BW, Kovacs FM, Lin CC, Maher CG, Pearson AM, Peul WC, Schoene ML, Turk DC, van Tulder MW, Terwee CB, Ostelo RW.

Core outcome measurement instruments for clinical trials in nonspecific low back pain.

Pain. 2018 Jan 24. doi: 10.1097/j.pain.0000000000001117. [Epub ahead of print] PMID: 29194127

Bruijnen STG, Verweij NJF, van Duivenvoorden LM, Bravenboer N, Baeten DLP, van Denderen CJ, van der Horst-Bruinsma IE, Voskuyl AE, Custers M, van de Ven PM, Bot JCJ, Boden BJH, Lammertsma AA, Hoekstra OSH, Raijmakers PGHM, van der Laken CJ.

Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.

Rheumatology (Oxford). 2018 Jan 9. doi: 10.1093/rheumatology/kex448. [Epub ahead of print] PMID: 29329443

Nurmohamed M, Choy E, Lula S, Kola B, DeMasi R, Accossato P.

The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review.

Drug Saf. 2018 Jan 9. doi: 10.1007/s40264-017-0628-9. [Epub ahead of print] Review. PMID: 29318514

Hanly JG, Li Q, Su L, Urowitz MB, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Clarke AE, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin P, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Steinsson K, Ramsey-Goldman R, Zoma AA, Manzi S, Nived O, Jonsen A, Khamashta MA, Alarcón GS, Chatham W, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Ramos-Casals M, Lim SS, Inanc M, Kalunian KC, Jacobsen S, Peschken CA, Kamen DL, Askanase A, Theriault C, Farewell V.

Cerebrovascular Events in Systemic Lupus Erythematosus.

Arthritis Care Res (Hoboken). 2018 Jan 5. doi: 10.1002/acr.23509. [Epub ahead of print] PMID: 29316357

Güler-Yüksel M, Hoes JN, Bultink IEM, Lems WF.

Glucocorticoids, Inflammation and Bone.

Calcif Tissue Int. 2018 Jan 8. doi: 10.1007/s00223-017-0335-7. [Epub ahead of print] Review. PMID: 29313071

December 2017

Bautista-Molano W, van der Heijde D, Landewé R, Lafaurie GI, de Ávila J, Valle-Oñate R, Romero-Sanchez C.

Is there a relationship between spondyloarthritis and periodontitis? A case-control study.

RMD Open. 2017 Dec 10;3(2):e000547. doi: 10.1136/rmdopen-2017-000547. eCollection 2017. PMID: 29299339

Houben E, Groenland SL, van der Heijden JW, Voskuyl AE, Doodeman HJ, Penne EL.

Relation between duration of the prodromal phase and renal damage in ANCA-associated vasculitis.

BMC Nephrol. 2017 Dec 29;18(1):378. doi: 10.1186/s12882-017-0797-x. PMID: 29287588

de Jong AJ, Pollastro S, Kwekkeboom JC, Andersen SN, Dorjée AL, Bakker AM, Alzaid F, Soprani A, Nelissen RGHH, Mullers JB, Venteclef N, de Vries N, Kloppenburg M, Toes REM, Ioan-Facsinay A.

Functional and phenotypical analysis of IL-6-secreting CD4+ T cells in human adipose tissue.

Eur J Immunol. 2017 Dec 28. doi: 10.1002/eji.201747037. [Epub ahead of print] PMID: 29283192

Glatt S, Baeten D, Baker T, Griffiths M, Ionescu L, Lawson ADG, Maroof A, Oliver R, Popa S, Strimenopoulou F, Vajjah P, Watling MIL, Yeremenko N, Miossec P, Shaw S.Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.

Ann Rheum Dis. 2017 Dec 23. pii: annrheumdis-2017-212127. doi: 10.1136/annrheumdis-2017-212127. [Epub ahead of print]  PMID: 29275332

van Hamburg JP, Tas SW.

Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis.

J Autoimmun. 2017 Dec 15. pii: S0896-8411(17)30801-6. doi: 10.1016/j.jaut.2017.12.006. [Epub ahead of print] Review. PMID: 29254845

Bautista-Molano W, Landewé R, Burgos-Vargas R, Maldonado-Cocco J, Moltó A, van den Bosch F, Valle-Oñate R, Dougados M, van der Heijde D.

Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA Study.

J Rheumatol. 2017 Dec 15. pii: jrheum.170520. doi: 10.3899/jrheum.170520. [Epub ahead of print] PMID: 29247152

Lems WF.
Bisphosphonates: a therapeutic option for knee osteoarthritis?

Ann Rheum Dis. 2017 Dec 13. pii: annrheumdis-2017-212364. doi: 10.1136/annrheumdis-2017-212364. [Epub ahead of print] No abstract available. PMID: 29237617

Nikiphorou E, van der Heijde D, Norton S, Landewé RB, Molto A, Dougados M, Van den Bosch FE, Ramiro S; Collaborators.

Inequity in biological DMARD prescription for spondyloarthritis across the globe: results from the ASAS-COMOSPA study.

Ann Rheum Dis. 2017 Dec 8. pii: annrheumdis-2017-212457. doi: 10.1136/annrheumdis-2017-212457. [Epub ahead of print] PMID: 29222349

Lems WF, Raterman HG.

Critical issues and current challenges in osteoporosis and fracture prevention. An overview of unmet needs.

Ther Adv Musculoskelet Dis. 2017 Dec;9(12):299-316. doi: 10.1177/1759720X17732562. Epub 2017 Oct 27. Review. PMID: 29201155

Cudejko T, van der Esch M, van der Leeden M, van den Noort JC, Roorda LD, Lems W, Twisk J, Steultjens M, Woodburn J, Harlaar J, Dekker J.

The immediate effect of a soft knee brace on pain, activity limitations, self-reported knee instability, and self-reported knee confidence in patients with knee osteoarthritis.

Arthritis Res Ther. 2017 Dec 1;19(1):260. doi: 10.1186/s13075-017-1456-0. PMID: 29191237

van Lunteren M, Ez-Zaitouni Z, Fongen C, Landewé R, Ramonda R, van der Heijde D, van Gaalen FA.

Disease activity decrease is associated with improvement in work productivity over 1 year in early axial spondyloarthritis (SPondyloArthritis Caught Early cohort).

Rheumatology (Oxford). 2017 Dec 1;56(12):2222-2228. doi: 10.1093/rheumatology/kex365. PMID: 29155961

Tsang-A-Sjoe MWP, Bultink IEM, Korswagen LA, van der Horst A, Rensink I, de Boer M, Hamann D, Voskuyl AE, Wouters D.

Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.

Mol Immunol. 2017 Dec;92:125-131. doi: 10.1016/j.molimm.2017.10.004. Epub 2017 Oct 26. PMID:29080553

November 2017

Barber MRW, Hanly JG, Su L, Urowitz MB, Pierre YS, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Fortin PR, Gladman DD, Sanchez-Guerrero J, Ramsey-Goldman R, Khamashta MA, Aranow C, Mackay M, Alarcón GS, Manzi S, Nived O, Jönsen A, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V, Clarke AE.

Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach.

Arthritis Care Res (Hoboken). 2017 Nov 28. doi: 10.1002/acr.23480. [Epub ahead of print] PMID: 29193883

Coates LC, FitzGerald O, Merola JF, Smolen J, van Mens LJJ, Bertheussen H, Boehncke WH, Callis Duffin K, Campbell W, de Wit M, Gladman D, Gottlieb A, James J, Kavanaugh A, Kristensen LE, Kvien TK, Luger T, McHugh N, Mease P, Nash P, Ogdie A, Rosen CF, Strand V, Tillett W, Veale DJ, Helliwell PS.

GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA.

Arthritis Rheumatol. 2017 Nov 28. doi: 10.1002/art.40391. [Epub ahead of print] PMID: 29193765

de Zwart AH, Dekker J, Lems W, Roorda LD, van der Esch M, van der Leeden M.

Factors associated with upper leg muscle strength in knee osteoarthritis: A scoping review.

J Rehabil Med. 2017 Nov 29. doi: 10.2340/16501977-2284. [Epub ahead of print] PMID: 29186637

Bergstra SA, Allaart CF, van den Berg R, Chopra A, Govind N, Huizinga TWJ, Landewe RBM.

Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis.

Arthritis Res Ther. 2017 Nov 22;19(1):258. doi: 10.1186/s13075-017-1468-9. PMID:29166919

Chiarotto A, Ostelo RW, Boers M, Terwee CB.

A systematic review highlights the need to investigate the content validity of patient-reported outcome measures for physical functioning in low back pain.

J Clin Epidemiol. 2017 Nov 14. pii: S0895-4356(17)30543-7. doi: 10.1016/j.jclinepi.2017.11.005. [Epub ahead of print] Review. PMID:29154811

Kavanaugh A, van Vollenhoven R, Fleischmann RM, Emery P, Sainsbury I, Florentinus S, Chen S, Guérette B, Kupper H, Smolen JS.

Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis.

Ann Rheum Dis. 2017 Nov 16. pii: annrheumdis-2017-211871. doi: 10.1136/annrheumdis-2017-211871. [Epub ahead of print] PMID:29146743

l’Ami MJ, Krieckaert CLM, Nurmohamed MT, van Vollenhoven RF, Rispens T, Boers M, Wolbink GJ.

Response to: Comment on l’Ami et al titled ‘Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial’ by den Broeder et al.

Ann Rheum Dis. 2017 Nov 13. pii: annrheumdis-2017-212602. doi: 10.1136/annrheumdis-2017-212602. [Epub ahead of print] No abstract available.PMID:29133475

Hansen IS, Hoepel W, Zaat SAJ, Baeten DLP, den Dunnen J.

Serum IgA Immune Complexes Promote Proinflammatory Cytokine Production by Human Macrophages, Monocytes, and Kupffer Cells through FcαRI-TLR Cross-Talk.

J Immunol. 2017 Nov 8. pii: ji1700883. doi: 10.4049/jimmunol.1700883. [Epub ahead of print]PMID:29118246

October 2017

 

Boers M.

More erronous statements about the use of frequentist statistical methods in medical research.

Clin Exp Rheumatol. 2017 Oct 26. [Epub ahead of print] No abstract available. PMID:29148414

Ter Wee MM, Coupé VM, den Uyl D, Blomjous BS, Kooijmans E, Kerstens PJ, Nurmohamed MT, van Schaardenburg D, Voskuyl AE, Boers M, Lems WF.

Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial.

RMD Open. 2017 Oct 25;3(2):e000502. doi: 10.1136/rmdopen-2017-000502. eCollection 2017. PMID:29119006

van Mens LJJ, van de Sande MGH, van Kuijk AWR, Baeten D, Coates LC.

Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort.

Ann Rheum Dis. 2017 Oct 28. pii: annrheumdis-2017-211998. doi: 10.1136/annrheumdis-2017-211998. [Epub ahead of print] PMID:29080861

Palmowski Y, Boers M, Buttgereit F.

Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?

Arthritis Care Res (Hoboken). 2017 Oct 26. doi: 10.1002/acr.23452. [Epub ahead of print] PMID:29073333

Cloos J, Roeten MS, Franke NE, van Meerloo J, Zweegman S, Kaspers GJ, Jansen G.

(Immuno)proteasomes as therapeutic target in acute leukemia.

Cancer Metastasis Rev. 2017 Oct 25. doi: 10.1007/s10555-017-9699-4. [Epub ahead of print] PMID:29071527

Boers M.

Graphics and statistics for cardiology: designing effective tables for presentation and publication.

Heart. 2017 Oct 13. pii: heartjnl-2017-311581. doi: 10.1136/heartjnl-2017-311581. [Epub ahead of print] Review. PMID:29030423

van Mens LJJ, van de Sande MGH, Fluri IA, Atiqi S, van Kuijk AWR, Baeten DLP.

Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice.

Arthritis Res Ther. 2017 Oct 10;19(1):226. doi: 10.1186/s13075-017-1424-8. PMID:29017591

Smith D, Hornstra J, Rocha M, Jansen G, Assaraf Y, Lasry I, Blom H, Smulders YM.

Folic Acid Impairs the Uptake of 5-Methyltetrahydrofolate in Human Umbilical Vascular Endothelial Cells.

J Cardiovasc Pharmacol. 2017 Oct;70(4):271-275. doi: 10.1097/FJC.0000000000000514.PMID:28991880

van Mens LJJ, van de Sande MGH, Baeten DLP.

New treatment paradigms in spondyloarthritis.

Curr Opin Rheumatol. 2017 Oct 4. doi: 10.1097/BOR.0000000000000457. [Epub ahead of print] PMID:28984648

Falkenburg WJJ, Kempers AC, Dekkers G, Ooijevaar-de Heer P, Bentlage AEH, Vidarsson G, van Schaardenburg D, Toes REM, Scherer HU, Rispens T.

Rheumatoid factors do not preferentially bind to ACPA-IgG or IgG with altered galactosylation.

Rheumatology (Oxford). 2017 Aug 4. doi: 10.1093/rheumatology/kex284. [Epub ahead of print]PMID:28977504

Bergstra SA, Landewé RBM, Huizinga TWJ, Allaart CF.

Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy.

Rheumatology (Oxford). 2017 Oct 1;56(10):1721-1728. doi: 10.1093/rheumatology/kex236. PMID:28957556

September 2017

Kroese SJ, Abheiden CNH, Blomjous BS, van Laar JM, Derksen RWHM, Bultink IEM, Voskuyl AE, Lely AT, de Boer MA, de Vries JIP, Fritsch-Stork RDE.

Maternal and Perinatal Outcome in Women with Systemic Lupus Erythematosus: A Retrospective Bicenter Cohort Study.

J Immunol Res. 2017;2017:8245879. doi: 10.1155/2017/8245879. Epub 2017 Sep 28.PMID:29094052

Houben E, Penne EL, Voskuyl AE, van der Heijden JW, Otten RHJ, Boers M, Hoekstra T.

Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies.

Rheumatology (Oxford). 2017 Sep 18. doi: 10.1093/rheumatology/kex338. [Epub ahead of print] PMID:29029294

Keystone EC, Breedveld FC, van der Heijde D, van Vollenhoven RF, Emery P, Smolen JS, Sainsbury I, Florentinus S, Kupper H, Chen K, Kavanaugh A.

Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone.

RMD Open. 2017 Sep 26;3(2):e000445. doi: 10.1136/rmdopen-2017-000445. eCollection 2017. PMID:29018564

Martínez-Feito A, Plasencia-Rodriguez C, Navarro-Compán V, Jurado T, Kneepkens EL, Wolbink GJ, Martín S, Ruiz Del Agua A, Navarro R, Mezcua A, Jochems A, Peiteado D, Bonilla MG, Balsa A, Pascual-Salcedo D.

Optimal concentration range of golimumab in patients with axial spondyloarthritis.

Clin Exp Rheumatol. 2017 Sep 15. [Epub ahead of print]PMID:28980904

Giovannetti E, Zucali PA, Assaraf YG, Funel N, Gemelli M, Stark M, Thunnissen E, Hou Z, Muller IB, Struijs EA, Perrino M, Jansen G, Matherly LH, Peters GJ.

Role of proton-coupled folate transporter in pemetrexed-resistance of mesothelioma: clinical evidence and new pharmacological tools.

Ann Oncol. 2017 Sep 1. doi: 10.1093/annonc/mdx499. [Epub ahead of print] PMID:28945836

l’Ami MJ, Krieckaert CL, Nurmohamed MT, van Vollenhoven RF, Rispens T, Boers M, Wolbink GJ.

Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial.

Ann Rheum Dis. 2017 Sep 22. pii: annrheumdis-2017-211781. doi: 10.1136/annrheumdis-2017-211781. [Epub ahead of print] PMID:28939629

Cudejko T, van der Esch M, van der Leeden M, Holla J, Roorda LD, Lems W, Dekker J.

Proprioception mediates the association between systemic inflammation and muscle weakness in patients with knee osteoarthritis: results from the Amsterdam Osteoarthritis cohort.

J Rehabil Med. 2017 Sep 20. doi: 10.2340/16501977-2272. [Epub ahead of print] PMID:28929165

Allaart CF, Markusse IM, Lems WF.

What have we learned from BeSt?

Clin Immunol. 2017 Sep 18. pii: S1521-6616(17)30676-9. doi: 10.1016/j.clim.2017.09.017. [Epub ahead of print]PMID:28927869

Schiff M, Takeuchi T, Fleischmann R, Gaich CL, DeLozier AM, Schlichting D, Kuo WL, Won JE, Carmack T, Rooney T, Durez P, Shaikh S, Hidalgo RP, van Vollenhoven R, Zerbini CAF.

Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.

Arthritis Res Ther. 2017 Sep 18;19(1):208. doi: 10.1186/s13075-017-1410-1. PMID:28923098

Kabala PA, Angiolilli C, Yeremenko N, Grabiec AM, Giovannone B, Pots D, Radstake TR, Baeten D, Reedquist KA.

Endoplasmic reticulum stress cooperates with Toll-like receptor ligation in driving activation of rheumatoid arthritis fibroblast-like synoviocytes.

Arthritis Res Ther. 2017 Sep 18;19(1):207. doi: 10.1186/s13075-017-1386-x. PMID:28923079

Briot K, Geusens P, Em Bultink I, Lems WF, Roux C.

Inflammatory diseases and bone fragility.

Osteoporos Int. 2017 Sep 15. doi: 10.1007/s00198-017-4189-7. [Epub ahead of print] Review. PMID:28916915

Bultink IEM.

Bone Disease in Connective Tissue Disease/Systemic Lupus Erythematosus.

Calcif Tissue Int. 2017 Sep 12. doi: 10.1007/s00223-017-0322-z. [Epub ahead of print] Review. PMID:28900675

Nagasawa M, Germar K, Blom B, Spits H.

Human CD5+ Innate Lymphoid Cells Are Functionally Immature and Their Development from CD34+ Progenitor Cells Is Regulated by Id2.

Front Immunol. 2017 Aug 31;8:1047. doi: 10.3389/fimmu.2017.01047. eCollection 2017. PMID:28912776

Levitsky A, Brismar K, Hafström I, Hambardzumyan K, Lourdudoss C, van Vollenhoven RF, Saevarsdottir S.

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial.

RMD Open. 2017 Aug 9;3(2):e000458. doi: 10.1136/rmdopen-2017-000458. eCollection 2017. PMID:28879052

Emamikia S, Gentline C, Chatzidionysiou K, Arnaud L, van Vollenhoven R.

Relationship between glucocorticoid dose and adverse events in systemic lupus erythematosus: data from a randomized clinical trial.

Scand J Rheumatol. 2017 Sep 1:1-10. doi: 10.1080/03009742.2017.1336570. [Epub ahead of print] PMID:28862513

Konijn NPC, van Tuyl LHD, Boers M, den Uyl D, Ter Wee MM, van der Wijden LKM, Bultink IEM, Kerstens PJSM, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.

Similar efficacy and safety of initial COBRA-light and COBRA therapy in rheumatoid arthritis: 4-year results from the COBRA-light trial.

Rheumatology (Oxford). 2017 Sep 1;56(9):1586-1596. doi: 10.1093/rheumatology/kex223. PMID:28859326

Al-Soudi A, Kaaij MH, Tas SW.

Endothelial cells: From innocent bystanders to active participants in immune responses.

Autoimmun Rev. 2017 Sep;16(9):951-962. doi: 10.1016/j.autrev.2017.07.008. Epub 2017 Jul 8. Review. PMID:28698091

August 2017

Zaal EA, Wu W, Jansen G, Zweegman S, Cloos J, Berkers CR.

Bortezomib resistance in multiple myeloma is associated with increased serine synthesis.

Cancer Metab. 2017 Aug 29;5:7. doi: 10.1186/s40170-017-0169-9. eCollection 2017. PMID:28855983

van Tuyl LHD, Boers M.

Rheumatoid arthritis: Remission – keeping the patient experience front and centre.

Nat Rev Rheumatol. 2017 Aug 31. doi: 10.1038/nrrheum.2017.139. [Epub ahead of print] No abstract available. PMID:28855692

Ez-Zaitouni Z, Landewé RBM, van der Heijde D, van Gaalen FA.

Alternative diagnoses in patients with chronic back pain not diagnosed with axial spondyloarthritis: data from the SPACE cohort.

Ann Rheum Dis. 2017 Aug 22. pii: annrheumdis-2017-212175. doi: 10.1136/annrheumdis-2017-212175. [Epub ahead of print] No abstract available. PMID:28830880

van Tok MN, Satumtira N, Dorris M, Pots D, Slobodin G, van de Sande MG, Taurog JD, Baeten DL, van Duivenvoorde LM.

Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats.

Front Immunol. 2017 Aug 7;8:920. doi: 10.3389/fimmu.2017.00920. eCollection 2017. PMID:28824645

Knoop J, van Tunen J, van der Esch M, Roorda LD, Dekker J, van der Leeden M, Lems WF.

Analgesic use in patients with knee and/or hip osteoarthritis referred to an outpatient center: a cross-sectional study within the Amsterdam Osteoarthritis Cohort.

Rheumatol Int. 2017 Aug 18. doi: 10.1007/s00296-017-3785-3. [Epub ahead of print] PMID:28821939

Winthrop KL, Strand V, van der Heijde D, Mease P, Crow M, Weinblatt M, Bathon J, Burmester GR, Dougados M, Kay J, Mariette X, Van Vollenhoven R, Sieper J, Melchers F, Breedfeld FC, Kalden J, Smolen JS, Furst DE.

The unmet need in rheumatology: Reports from the targeted therapies meeting 2017.

Clin Immunol. 2017 Aug 12. pii: S1521-6616(17)30543-0. doi: 10.1016/j.clim.2017.08.009. [Epub ahead of print] PMID:28811201

Tolend MA, Twilt M, Cron RQ, Tzaribachev N, Guleria S, von Kalle T, Koos B, Miller E, Stimec J, Vaid Y, Larheim TA, Herlin T, Spiegel L, Inarejos E, Moineddin R, van Rossum MA, Saurenmann RK, Doria AS, Kellenberger CJ.

Towards Establishing a Standardized Magnetic Resonance Imaging Scoring System for Temporomandibular Joints in Juvenile Idiopathic Arthritis.

Arthritis Care Res (Hoboken). 2017 Aug 13. doi: 10.1002/acr.23340. [Epub ahead of print] PMID:28805021

Lensen KDF, van Sijl AM, Voskuyl AE, van der Laken CJ, Heymans MW, Comans EFI, Nurmohamed MT, Smulders YM, Boellaard R.

Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT.

PLoS One. 2017 Aug 11;12(8):e0181847. doi: 10.1371/journal.pone.0181847. eCollection 2017. PMID:28800625

Kneepkens EL, Pouw MF, Wolbink GJ, Schaap T, Nurmohamed MT, de Vries A, Rispens T, Bloem K.

Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases.

Br J Clin Pharmacol. 2017 Aug 9. doi: 10.1111/bcp.13371. [Epub ahead of print] PMID:28791718

Tak PP, Doorenspleet ME, de Hair MJH, Klarenbeek PL, van Beers-Tas MH, van Kampen AHC, van Schaardenburg D, Gerlag DM, Baas F, de Vries N.

Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.

Ann Rheum Dis. 2017 Aug 8. pii: annrheumdis-2017-211351. doi: 10.1136/annrheumdis-2017-211351. [Epub ahead of print] PMID:28790026

Orr C, Sousa E, Boyle DL, Buch MH, Buckley CD, Cañete JD, Catrina AI, Choy EHS, Emery P, Fearon U, Filer A, Gerlag D, Humby F, Isaacs JD, Just SA, Lauwerys BR, Le Goff B, Manzo A, McGarry T, McInnes IB, Najm A, Pitzalis C, Pratt A, Smith M, Tak PP, Thurlings R, Fonseca JE, Veale DJ.

Synovial tissue research: a state-of-the-art review.

Nat Rev Rheumatol. 2017 Aug;13(8):463-475. doi: 10.1038/nrrheum.2017.115. Epub 2017 Jul 13. Review. PMID:28701760

July 2017

van der Velde RY, Bours SPG, Wyers CE, Lems WF, Geusens PPMM, van den Bergh JPW.

Effect of implementation of guidelines on assessment and diagnosis of vertebral fractures in patients older than 50 years with a recent non-vertebral fracture.

Osteoporos Int. 2017 Jul 26. doi: 10.1007/s00198-017-4147-4. [Epub ahead of print] PMID:28748385

Ruwaard J, l’Ami MJ, Marsman AF, Kneepkens EL, van Denderen JC, van der Horst-Bruinsma IE, Nurmohamed MT, Wolbink G.

Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab.

Scand J Rheumatol. 2017 Jul 26:1-5. doi: 10.1080/03009742.2017.1330419. [Epub ahead of print] PMID:28745108

Chin Jen Sem JP, van der Leeden M, Visscher CM, Britsemmer K, Turk SA, Dekker J, van Schaardenburg D, Lobbezoo F.

Prevalence, Course, and Associated Factors of Pain in the Temporomandibular Joint in Early Rheumatoid Arthritis: Results of a Longitudinal Cohort Study.

J Oral Facial Pain Headache. Summer 2017;31(3):233-239. doi: 10.11607/ofph.1606. PMID:28738108

Ibáñez Vodnizza SE, Nurmohamed MT, Visman IM, van Denderen JC, Lems WF, Jaime F, van der Horst-Bruinsma IE.

Fat Mass Lowers the Response to Tumor Necrosis Factor-α Blockers in Patients with Ankylosing Spondylitis.

J Rheumatol. 2017 Jul 15. pii: jrheum.170094. doi: 10.3899/jrheum.170094. [Epub ahead of print] PMID:28711878

Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewé R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, Vlam K, Heijde DV.

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.

Ann Rheum Dis. 2017 Jul 6. pii: annrheumdis-2017-211734. doi: 10.1136/annrheumdis-2017-211734. [Epub ahead of print] PMID:28684559

Dougados M, Sepriano A, Molto A, van Lunteren M, Ramiro S, de Hooge M, van den Berg R, Navarro Compan V, Demattei C, Landewé R, van der Heijde D.

Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort.

Ann Rheum Dis. 2017 Jul 6. pii: annrheumdis-2017-211596. doi: 10.1136/annrheumdis-2017-211596. [Epub ahead of print] PMID:28684556

Edelaar LM, van Dieën JH, van der Esch M, Roorda LD, Dekker J, Lems WF, van der Leeden M.

Nonlinear relationship between isokinetic muscle strength and activity limitations in patients with knee osteoarthritis: Results of the Amsterdam-Osteoarthritis cohort.

J Rehabil Med. 2017 Jul 7;49(7):598-605. doi: 10.2340/16501977-2252. PMID:28661545

Bossini-Castillo L, Campillo-Davó D, López-Isac E, Carmona FD, Simeon CP, Carreira P, Callejas-Rubio JL, Castellví I, Fernández-Nebro A, Rodríguez-Rodríguez L, Rubio-Rivas M, García-Hernández FJ, Madroñero AB, Beretta L, Santaniello A, Lunardi C, Airó P, Hoffmann-Vold AM, Kreuter A, Riemekasten G, Witte T, Hunzelmann N, Vonk MC, Voskuyl AE, de Vries-Bouwstra J, Shiels P, Herrick A, Worthington J, Radstake TRDJ, Martin J; Spanish Scleroderma Group.

An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.

J Rheumatol. 2017 Jul 1. pii: jrheum.161369. doi: 10.3899/jrheum.161369. [Epub ahead of print] PMID:28668810

Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP.

Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis.

J Intern Med. 2017 Jul;282(1):64-75. doi: 10.1111/joim.12626. Epub 2017 May 26. PMID:28547815

June 2017

Agca R, Heslinga M, Kneepkens EL, van Dongen C, Nurmohamed MT.

The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic Arthritis.

J Rheumatol. 2017 Jun 1. pii: jrheum.161418. doi: 10.3899/jrheum.161418. [Epub ahead of print]PMID:28572461

Hemke R, Tzaribachev N, Nusman CM, van Rossum MAJ, Maas M, Doria AS.

Magnetic Resonance Imaging (MRI) of the Knee as an Outcome Measure in Juvenile Idiopathic Arthritis: An OMERACT Reliability Study on MRI Scales.

J Rheumatol. 2017 Jun 1. pii: jrheum.160821. doi: 10.3899/jrheum.160821. [Epub ahead of print] PMID:28572469

Genovese MC, Kremer JM, van Vollenhoven RF, Alten R, Jose Scali J, Kelman A, Dimonaco S, Brockwell L.

Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis.

Arthritis Rheumatol. 2017 Jun 8. doi: 10.1002/art.40176. [Epub ahead of print] PMID:28597609

Lesuis N, van Vollenhoven RF, Akkermans RP, Verhoef LM, Hulscher ME, den Broeder AA.

Rheumatologists’ guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.

Clin Exp Rheumatol. 2017 Jun 5. [Epub ahead of print] PMID:28598775

Ibáñez Vodnizza S, Visman IM, van Denderen C, Lems WF, Jaime F, Nurmohamed MT, van der Horst-Bruinsma IE.

Muscle wasting in male TNF-α blocker naïve ankylosing spondylitis patients: a comparison of gender differences in body composition.

Rheumatology (Oxford). 2017 Jun 12. doi: 10.1093/rheumatology/kex187. [Epub ahead of print] PMID:28605535

Bouman CA, Herwaarden NV, van den Hoogen FH, Fransen J, van Vollenhoven RF, Bijlsma JW, Maas AV, den Broeder AA.

Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study – a randomised controlled pragmatic non-inferiority strategy trial.

Ann Rheum Dis. 2017 Jun 12. pii: annrheumdis-2017-211169. doi: 10.1136/annrheumdis-2017-211169. [Epub ahead of print] PMID:28606961

Tang MW, Garcia S, Malvar Fernandez B, Gerlag DM, Tak PP, Reedquist KA.

Rheumatoid arthritis and psoriatic arthritis synovial fluid stimulates prolactin production by macrophages.

J Leukoc Biol. 2017 Jun 22. pii: jlb.2A0317-115RR. doi: 10.1189/jlb.2A0317-115RR. [Epub ahead of print]PMID:28642278

Grasso C, Jansen G, Giovannetti E.

Drug resistance in pancreatic cancer: Impact of altered energy metabolism.

Crit Rev Oncol Hematol. 2017 Jun;114:139-152. doi: 10.1016/j.critrevonc.2017.03.026. Epub 2017 Mar 23. Review. PMID:28477742

May 2017

Chandrupatla DMSH, Jansen G, Vos R, Verlaan M, Chen Q, Low PS, Windhorst AD, Lammertsma AA, van der Laken CJ, Molthoff CFM.

In-vivo monitoring of anti-folate therapy in arthritic rats using [18F]fluoro-PEG-folate and positron emission tomography.

Arthritis Res Ther. 2017 May 31;19(1):114. doi: 10.1186/s13075-017-1325-x. PMID:28569209

van Mens LJJ, Turina MC, van de Sande MGH, Nurmohamed MT, van Kuijk AWR, Baeten DLP.

Residual disease activity in psoriatic arthritis: discordance between the rheumatologist’s opinion and minimal disease activity measurement.

Rheumatology (Oxford). 2017 May 24. doi: 10.1093/rheumatology/kex183. [Epub ahead of print] PMID:28541484

Wei JC, Baeten D, Sieper J, Deodhar A, Bhosekar V, Martin R, Porter B.

Efficacy and safety of secukinumab in Asian patients with active ankylosing spondylitis: 52-week pooled results from two phase 3 studies.

Int J Rheum Dis. 2017 May;20(5):589-596. doi: 10.1111/1756-185X.13094. Epub 2017 May 25. PMID:28544533

Oude Voshaar MAH, Ghiti Moghadam M, Vonkeman HE, Ten Klooster PM, van Schaardenburg D, Tekstra J, Visser H, van de Laar MAFJ, Jansen TL.

Measuring Disease Exacerbation and Flares in Rheumatoid Arthritis: Comparison of Commonly Used Disease Activity Indices and Individual Measures.

J Rheumatol. 2017 May 15. pii: jrheum.160915. doi: 10.3899/jrheum.160915. [Epub ahead of print] PMID:28507187

Lems WF.

Is Fragility Fracture a Strong Risk Factor for a Cardiovascular Event in Rheumatoid Arthritis? The Challenge of Dealing with Multiple Comorbidities.

J Rheumatol. 2017 May;44(5):545-546. doi: 10.3899/jrheum.170202. No abstract available. PMID:28461515

Turk SA, Heslinga SC, Dekker J, Britsemmer L, van der Lugt V, Lems WF, van Schaardenburg D, Nurmohamed MT.

The Relationship Between Cardiac Conduction Times, Cardiovascular Risk Factors, and Inflammation in Patients with Early Arthritis.

J Rheumatol. 2017 May;44(5):580-586. doi: 10.3899/jrheum.161184. Epub 2017 Apr 1. PMID:28365582

April 2017

Chiarotto A, Ostelo RW, Turk DC, Buchbinder R, Boers M.

Core outcome sets for research and clinical practice.

Braz J Phys Ther. 2017 Mar – Apr;21(2):77-84. doi: 10.1016/j.bjpt.2017.03.001. Epub 2017 Mar 18. Review. PMID:28460714

van der Meulen PM, Barendregt AM, Cuadrado E, Magro-Checa C, Steup-Beekman GM, Schonenberg-Meinema D, Van den Berg JM, Li QZ, Baars PA, Wouters D, Voskuyl AE, Ten Berge IRJM, Huizinga TWJ, Kuijpers TW.

Protein array autoantibody profiles to determine diagnostic markers for neuropsychiatric systemic lupus erythematosus.

Rheumatology (Oxford). 2017 Apr 27. doi: 10.1093/rheumatology/kex073. [Epub ahead of print] PMID:28460084

van Schie KA, Ooijevaar-De Heer P, Kruithof S, Plasencia C, Jurado T, Pascual Salcedo D, Brandse JF, d’Haens GR, Wolbink GJ, Rispens T.

Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies.

Ann Rheum Dis. 2017 Apr 28. pii: annrheumdis-2016-211035. doi: 10.1136/annrheumdis-2016-211035. [Epub ahead of print] PMID:28455438

Ez-Zaitouni Z, van Lunteren M, Bakker PAC, van den Berg R, Reijnierse M, Fagerli KM, Landewé RBM, Ramonda R, Jacobsson LTH, van Gaalen FA, van der Heijde D.

The influence of discrepant imaging judgements on the classification of axial spondyloarthritis is limited: a replication in the SpondyloArthritis Caught Early (SPACE) cohort.

Ann Rheum Dis. 2017 Apr 17. pii: annrheumdis-2017-211553. doi: 10.1136/annrheumdis-2017-211553. [Epub ahead of print] No abstract available.  PMID:28416518

Boers M.

Observational studies on glucocorticoids are harmful!

Lupus Sci Med. 2017 Apr 7;4(1):e000219. doi: 10.1136/lupus-2017-000219. eCollection 2017. No abstract available. PMID:28409017

Kerstens FG, Turkstra F, Atalay S, van Vugt RM, Swearingen CJ, Yazici Y.

Adherence to guidelines for the treatment of Behçet’s syndrome in New York and Amsterdam.

Clin Exp Rheumatol. 2017 Apr 13. [Epub ahead of print] PMID:28406760

Tang MW, van Nierop FS, Koopman FA, Eggink HM, Gerlag DM, Chan MW, Zitnik R, Vaz FM, Romijn JA, Tak PP, Soeters MR.

Single vagus nerve stimulation reduces early postprandial C-peptide levels but not other hormones or postprandial metabolism.

Clin Rheumatol. 2017 Apr 8. doi: 10.1007/s10067-017-3618-5. [Epub ahead of print] PMID:28389989

Noben C, van Vilsteren M, Boot C, Steenbeek R, van Schaardenburg D, R Anema J, Evers S, Nijhuis F, de Rijk A.

Economic evaluation of an intervention program with the aim to improve at-work productivity for workers with rheumatoid arthritis.

J Occup Health. 2017 Apr 5. doi: 10.1539/joh.16-0082-OA. [Epub ahead of print] PMID:28381814

March 2017

Lourdudoss C, Di Giuseppe D, Wolk A, Westerlind H, Klareskog L, Alfredsson L, van Vollenhoven RF, Lampa J.

Dietary Intake of Polyunsaturated Fatty Acids and Pain in spite of Inflammatory Control among Methotrexate Treated Early Rheumatoid Arthritis Patients.

Arthritis Care Res (Hoboken). 2017 Mar 28. doi: 10.1002/acr.23245. [Epub ahead of print] PMID:28371257

de Jong TD, Sellam J, Agca R, Vosslamber S, Witte BI, Tsang-A-Sjoe M, Mantel E, Bijlsma JW, Voskuyl AE, Nurmohamed MT, Verweij CL, Mariette X.

A multi-parameter response prediction model for rituximab in rheumatoid arthritis.

Joint Bone Spine. 2017 Mar 28. pii: S1297-319X(17)30054-4. doi: 10.1016/j.jbspin.2017.02.015. [Epub ahead of print]PMID:28363827

Crins MHP, Terwee CB, Klausch T, Smits N, de Vet HCW, Westhovens R, Cella D, Cook KF, Revicki DA, van Leeuwen J, Boers M, Dekker J, Roorda LD.

The Dutch-Flemish PROMIS Physical Function item bank exhibited strong psychometric properties in patients with chronic pain.

J Clin Epidemiol. 2017 Mar 28. pii: S0895-4356(16)30364-X. doi: 10.1016/j.jclinepi.2017.03.011. [Epub ahead of print]PMID:28363734

Chatzidionysiou K, Emamikia S, Nam J, Ramiro S, Smolen J, van der Heijde D, Dougados M, Bijlsma J, Burmester G, Scholte M, van Vollenhoven R, Landewé R.

Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.

Ann Rheum Dis. 2017 Mar 29. pii: annrheumdis-2016-210711. doi: 10.1136/annrheumdis-2016-210711. [Epub ahead of print] PMID:28356243

Fleischmann R, van Vollenhoven RF, Vencovský J, Alten R, Davies O, Mountian I, de Longueville M, Carter D, Choy E.

Long-Term Maintenance of Certolizumab Pegol Safety and Efficacy, in Combination with Methotrexate and as Monotherapy, in Rheumatoid Arthritis Patients.

Rheumatol Ther. 2017 Mar 28. doi: 10.1007/s40744-017-0060-8. [Epub ahead of print] PMID:28353191

Spanjer MJ, Bultink IE, de van der Schueren MA, Voskuyl AE.

Prevalence of malnutrition and validation of bioelectrical impedance analysis for the assessment of body composition in patients with systemic sclerosis.

Rheumatology (Oxford). 2017 Mar 7. doi: 10.1093/rheumatology/kex014. [Epub ahead of print] PMID:28340004

Reshetova P, van Schaik BD, Klarenbeek PL, Doorenspleet ME, Esveldt RE, Tak PP, Guikema JE, de Vries N, van Kampen AH.

Computational Model Reveals Limited Correlation between Germinal Center B-Cell Subclone Abundancy and Affinity: Implications for Repertoire Sequencing.

Front Immunol. 2017 Mar 6;8:221. doi: 10.3389/fimmu.2017.00221. eCollection 2017 Mar 6. PMID:28321219

van den Brandt S, Zbinden A, Baeten D, Villiger PM, Østensen M, Förger F.
Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients.

Arthritis Res Ther. 2017 Mar 20;19(1):64. doi: 10.1186/s13075-017-1269-1. PMID:28320445

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JM, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Ann Rheum Dis. 2017 Mar 6. pii: annrheumdis-2016-210715. doi: 10.1136/annrheumdis-2016-210715. [Epub ahead of print] PMID:28264816

Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D.

In patients with axial spondyloarthritis, inflammation on MRI of the spine is longitudinally related to disease activity only in men: 2 years of the axial spondyloarthritis DESIR cohort.

Ann Rheum Dis. 2017 Mar 3. pii: annrheumdis-2016-210697. doi: 10.1136/annrheumdis-2016-210697. [Epub ahead of print] No abstract available. PMID:28258059

Györi N, Giannakou I, Chatzidionysiou K, Magder L, van Vollenhoven RF, Petri M.

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.

Lupus Sci Med. 2017 Feb 8;4(1):e000192. doi: 10.1136/lupus-2016-000192. eCollection 2017 Feb 8. PMID:28243457

Shikhagaie MM, Germar K, Bal SM, Ros XR, Spits H.

Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.

Nat Rev Rheumatol. 2017 Mar;13(3):164-173. doi: 10.1038/nrrheum.2016.218. Epub 2017 Feb 2. Review. PMID:28148916

Nurmohamed MT.

Therapy: Cardiovascular safety of celecoxib, naproxen and ibuprofen.

Nat Rev Rheumatol. 2017 Mar;13(3):136-138. doi: 10.1038/nrrheum.2017.4. Epub 2017 Jan 27. No abstract available. PMID:28127041

Rasch LA, de van der Schueren MA, van Tuyl LH, Bultink IE, de Vries JH, Lems WF.
Content Validity of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis.

Calcif Tissue Int. 2017 Mar;100(3):271-277. doi: 10.1007/s00223-016-0221-8. PMID:28083636

 

February 2017

Musters A, Tas SW.
How to monitor safety and efficacy of biologic treatment in rare, therapy-refractory immune-mediated inflammatory diseases?: Making the right clinical decisions for rare diseases with the right tools.

Rheumatology (Oxford). 2017 Feb 22. doi: 10.1093/rheumatology/kex016. [Epub ahead of print] No abstract available. PMID:28339729

van den Oever IA, Heslinga M, Griep EN, Griep-Wentink HR, Schotsman R, Cambach W, Dijkmans BA, Smulders YM, Lems WF, Boers M, Voskuyl AE, Peters MJ, van Schaardenburg D, Nurmohamed MT.

Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project.

Rheumatology (Oxford). 2017 Feb 10. doi: 10.1093/rheumatology/kew497. [Epub ahead of print] No abstract available.PMID:28199724

Hissink Muller PC, Brinkman DM, Schonenberg D, Koopman-Keemink Y, Brederije IC, Bekkering WP, Kuijpers TW, van Rossum MA, van Suijlekom-Smit LW, van den Berg JM, Allaart CF, Ten Cate R.

A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis: initial 3-months results of the BeSt for Kids-study.

Pediatr Rheumatol Online J. 2017 Feb 6;15(1):11. doi: 10.1186/s12969-017-0138-4. PMID:28166785

Doorenspleet ME, Westera L, Peters CP, Hakvoort TB, Esveldt RE, Vogels E, van Kampen AH, Baas F, Buskens C, Bemelman WA, D’Haens G, Ponsioen CY, Te Velde AA, de Vries N, van den Brink GR.

Profoundly expanded T-cell clones in the inflamed and uninflamed intestine of patients with Crohn’s disease.

J Crohns Colitis. 2017 Feb 2. doi: 10.1093/ecco-jcc/jjx012. [Epub ahead of print] No abstract available. PMID:28158397

January 2017

Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Manzi S, Nived O, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Buyon J, Mahler M, Fritzler MJ.

The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.

Lupus. 2017 Jan 1:961203317692437. doi: 10.1177/0961203317692437. [Epub ahead of print] PMID:28420054

Sepriano A, Rubio R, Ramiro S, Landewé R, van der Heijde D.

Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis.

Ann Rheum Dis. 2017 Feb 8. pii: annrheumdis-2016-210747. doi: 10.1136/annrheumdis-2016-210747. [Epub ahead of print]. PMID:28179264

Sepriano A, Regel A, van der Heijde D, Braun J, Baraliakos X, Landewé R, Van den Bosch F, Falzon L, Ramiro S.

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.

RMD Open. 2017 Jan 27;3(1):e000396. doi: 10.1136/rmdopen-2016-000396. PMID:28176964

López-Isac E, Bossini-Castillo L, Palma AB, Assassi S, Simeón CP, Ortego-Centeno N, Vicente E, Tolosa C, Rubio-Rivas M, Román-Ivorra JA; Spanish Scleroderma Group., Beretta L, Moroncini G, Hunzelmann N, Distler JH, Riemekasten G, de Vries-Bouwstra J, Voskuyl AE, Radstake TR, Herrick A, Denton CP, Fonseca C, Mayes MD, Martín J.

Analysis of ATP8B4 F436L missense variant in a large Systemic sclerosis cohort.

Arthritis Rheumatol. 2017 Jan 31. doi: 10.1002/art.40058. [Epub ahead of print] No abstract available. PMID:28141915

Damen MS, Agca R, Holewijn S, de Graaf J, Dos Santos JC, van Riel PL, Fransen J, Coenen MJ, Nurmohamed MT, Netea MG, Dinarello CA, Joosten LA, Heinhuis B, Popa CD.

IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis.

Sci Rep. 2017 Jan 30;7:41629. doi: 10.1038/srep41629. PMID:28134327

Houben E, van der Heijden JW, van Dam B, Bax WA, Voskuyl AE, Penne EL.

Screening for renal involvement in ANCA-associated vasculitis: room for improvement?

Neth J Med. 2017 Jan;75(1):21-26. PMID:28124664

Turina MC, Yeremenko N, van Gaalen F, van Oosterhout M, Berg IJ, Ramonda R, Lebre CM, Landewé R, Baeten D.

Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort.

RMD Open. 2017 Jan 11;3(1):e000319. doi: 10.1136/rmdopen-2016-000319. PMID:28123777

Angiolilli C, Baeten DL, Radstake TR, Reedquist KA.

The acetyl code in rheumatoid arthritis and other rheumatic diseases.

Epigenomics. 2017 Jan 19. doi: 10.2217/epi-2016-0136. [Epub ahead of print]. PMID:28102705

van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J.

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.

Ann Rheum Dis. 2017 Jan 13. pii: annrheumdis-2016-210770. doi: 10.1136/annrheumdis-2016-210770. [Epub ahead of print]. PMID:28087505

l’Ami MJ, Kneepkens EL, Nurmohamed MT, Krieckaert CL, Visman IM, Wolbink GJ.

Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate.

Clin Exp Rheumatol. 2017 Jan 5. [Epub ahead of print] PMID:28079512

Carmona FD, Vaglio A, Mackie SL, Hernández-Rodríguez J, Monach PA, Castañeda S, Solans R, Morado IC, Narváez J, Ramentol-Sintas M, Pease CT, Dasgupta B, Watts R, Khalidi N, Langford CA, Ytterberg S, Boiardi L, Beretta L, Govoni M, Emmi G, Bonatti F, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Sailler L, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Brouwer E, Daikeler T, Berger CT, Molloy ES, O’Neill L, Blockmans D, Lie BA, Mclaren P, Vyse TJ, Wijmenga C, Allanore Y, Koeleman BP; Spanish CGA Group.; UKGCA Consortium.; Vasculitis Clinical Research Consortium., Barrett JH, Cid MC, Salvarani C, Merkel PA, Morgan AW, González-Gay MA, Martín J.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

Am J Hum Genet. 2017 Jan 5;100(1):64-74. doi: 10.1016/j.ajhg.2016.11.013. PMID:28041642

Falkenburg WJ, van Schaardenburg D, Ooijevaar-de Heer P, Tsang-A-Sjoe MW, Bultink IE, Voskuyl AE, Bentlage AE, Vidarsson G, Wolbink G, Rispens T.

Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.

J Immunol. 2017 Jan 1;198(1):82-93. PMID:27864476

 

ARC Publications 2016

December 2016

Sciarrillo R, Wojtuszkiewicz A, Kooi IE, Gómez VE, Boggi U, Jansen G, Kaspers GJ, Cloos J, Giovannetti E.

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models.

J Vis Exp. 2016 Dec 9;(118). doi: 10.3791/54714. PMID:28060337

Jamnitski A, van Hall O, de Vries N, van der Valk P, Lems WF, van der Horst-Bruinsma IE.

Symptomatic unilateral sacroiliitis as a first presenting feature of IgG4-related disease with successful response to treatment after 1 year of follow-uparticle.

Rheumatology (Oxford). 2016 Dec 30. pii: kew481. doi: 10.1093/rheumatology/kew481. [Epub ahead of print] No abstract available. PMID:28039416

van den Hoek J, Boshuizen HC, Roorda LD, Tijhuis GJ, Nurmohamed MT, van den Bos GA, Dekker J.

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study.

Rheumatol Int. 2016 Dec 28. doi: 10.1007/s00296-016-3638-5. [Epub ahead of print]PMID:28032180

Palmowski Y, Buttgereit T, Dejaco C, Bijlsma JW, Matteson EL, Voshaar M, Boers M, Buttgereit F.

The “official view” on glucocorticoids in rheumatoid arthritis. A systematic review of international guidelines and consensus statements.

Arthritis Care Res (Hoboken). 2016 Dec 28. doi: 10.1002/acr.23185. [Epub ahead of print] PMID:28029750

Tarp S, Eric Furst D, Boers M, Luta G, Bliddal H, Tarp U, Heller Asmussen K, Brock B, Dossing A, Schjødt Jørgensen T, Thirstrup S, Christensen R.

Risk of serious adverse effects of biological and targeted drugs in patients with rheumatoid arthritis: a systematic review meta-analysis.

Rheumatology (Oxford). 2016 Dec 24. pii: kew442. doi: 10.1093/rheumatology/kew442. [Epub ahead of print]. PMID:28013201

Lems WF, Dreinhöfer KE, Bischoff-Ferrari H, Blauth M, Czerwinski E, da Silva J, Herrera A, Hoffmeyer P, Kvien T, Maalouf G, Marsh D, Puget J, Puhl W, Poor G, Rasch L, Roux C, Schüler S, Seriolo B, Tarantino U, van Geel T, Woolf A, Wyers C, Geusens P.

EULAR/EFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures.

Ann Rheum Dis. 2016 Dec 22. pii: annrheumdis-2016-210289. doi: 10.1136/annrheumdis-2016-210289. [Epub ahead of print] PMID:28007756

Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Wallman JK, Ernestam S, Bolce RJ, van Vollenhoven RF.

A multi-biomarker disease activity score and the choice of second-line therapy in early rheumatoid arthritis after methotrexate failure.

Arthritis Rheumatol. 2016 Dec 19. doi: 10.1002/art.40019. [Epub ahead of print].PMID:27992691

Bergstra SA, Allaart CF, Stijnen T, Landewé R.

Meta-regression of a dose-response relationship of methotrexate in mono- and combination therapy in DMARD naive early rheumatoid arthritis patients.

Arthritis Care Res (Hoboken). 2016 Dec 19. doi: 10.1002/acr.23164. [Epub ahead of print]. PMID:27992656

van der Helm-van Mil A, Landewé R.

Appropriate use of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis.

Ann Rheum Dis. 2016 Dec 15. pii: annrheumdis-2016-210859. doi: 10.1136/annrheumdis-2016-210859. [Epub ahead of print] No abstract available.PMID:27979872

Peterfy C, Strand V, Tian L, Østergaard M, Lu Y, DiCarlo J, Countryman P, Deodhar A, Landewé R, Ranganath VK, Troum O, Conaghan PG.

Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials.

Ann Rheum Dis. 2016 Dec 14. pii: annrheumdis-2016-210311. doi: 10.1136/annrheumdis-2016-210311. [Epub ahead of print]. PMID:27974302

Braun J, Baraliakos X, Deodhar A, Baeten D, Sieper J, Emery P, Readie A, Martin R, Mpofu S, Richards HB; MEASURE 1 study group.

Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study.

Ann Rheum Dis. 2016 Dec 13. pii: annrheumdis-2016-209730. doi: 10.1136/annrheumdis-2016-209730. [Epub ahead of print]. PMID:27965257

de Jong TD, Blits M, de Ridder S, Vosslamber S, Wolbink G, Nurmohamed MT, Verweij CL.

Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters.

Arthritis Res Ther. 2016 Dec 12;18(1):290.PMID:27955694

Aleyd E, Al M, Tuk CW, van der Laken CJ, van Egmond M.

IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI.

J Immunol. 2016 Dec 15;197(12):4552-4559. PMID:27913645

Levels MJ, Van Tok MN, Cantaert T, Cañete JD, Kroese FG, Germar K, Spits H, Baeten DL, Yeremenko NG.

The transcriptional co-activator Bob1 is associated with pathologic B cell responses in autoimmune tissue inflammation.

Arthritis Rheumatol. 2016 Dec 1. doi: 10.1002/art.39993. [Epub ahead of print]. PMID:27907250

Smolen JS, Burmester GR, Combe B, Curtis JR, Hall S, Haraoui B, van Vollenhoven R, Cioffi C, Ecoffet C, Gervitz L, Ionescu L, Peterson L, Fleischmann R.
Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.

Lancet. 2016 Dec 3;388(10061):2763-2774. doi: 10.1016/S0140-6736(16)31651-8. PMID:2786380

 

November 2016

van Tuyl LH, Sadlonova M, Hewlett S, Davis B, Flurey C, Goel N, Gossec L, Heegaard Brahe C, Hill CL, Hoogland W, Kirwan J, Hetland ML, van Schaardenburg D, Smolen JS, Stamm T, Voshaar M, Wells GA, Boers M.

The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission.

Ann Rheum Dis. 2016 Nov 30. pii: annrheumdis-2016-209835. doi: 10.1136/annrheumdis-2016-209835. [Epub ahead of print]. PMID:27903508

van Vollenhoven R, Voskuyl A, Bertsias G, Aranow C, Aringer M, Arnaud L, Askanase A, Balážová P, Bonfa E, Bootsma H, Boumpas D, Bruce I, Cervera R, Clarke A, Coney C, Costedoat-Chalumeau N, Czirják L, Derksen R, Doria A, Dörner T, Fischer-Betz R, Fritsch-Stork R, Gordon C, Graninger W, Györi N, Houssiau F, Isenberg D, Jacobsen S, Jayne D, Kuhn A, Le Guern V, Lerstrøm K, Levy R, Machado-Ribeiro F, Mariette X, Missaykeh J, Morand E, Mosca M, Inanc M, Navarra S, Neumann I, Olesinska M, Petri M, Rahman A, Rekvig OP, Rovensky J, Shoenfeld Y, Smolen J, Tincani A, Urowitz M, van Leeuw B, Vasconcelos C, Voss A, Werth VP, Zakharova H, Zoma A, Schneider M, Ward M.

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).

Ann Rheum Dis. 2016 Nov 24. pii: annrheumdis-2016-209519. doi: 10.1136/annrheumdis-2016-209519. [Epub ahead of print]. PMID:27884822

van der Vorst EP, Theodorou K, Wu Y, Hoeksema MA, Goossens P, Bursill CA, Aliyev T, Huitema LF, Tas SW, Wolfs IM, Kuijpers MJ, Gijbels MJ, Schalkwijk CG, Koonen DP, Abdollahi-Roodsaz S, McDaniels K, Wang CC, Leitges M, Lawrence T, Plat J, Van Eck M, Rye KA, Touqui L, de Winther MP, Biessen EA, Donners MM.

High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling.

Cell Metab. 2016 Nov 16. pii: S1550-4131(16)30544-7. doi: 10.1016/j.cmet.2016.10.013. [Epub ahead of print]. PMID:27866837

Maracle CX, Kucharzewska P, Helder B, van der Horst C, Correa de Sampaio P, Noort AR, van Zoest K, Griffioen AW, Olsson H, Tas SW.
Targeting non-canonical nuclear factor-κB signalling attenuates neovascularization in a novel 3D model of rheumatoid arthritis synovial angiogenesis.

Rheumatology (Oxford). 2016 Nov 17. pii: kew393. [Epub ahead of print].PMID:27864565

Tsang-A-Sjoe MW, Bultink IE, Heslinga M, Voskuyl AE.

Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.

Rheumatology (Oxford). 2016 Nov 1. pii: kew377. [Epub ahead of print]. PMID:27803306

Bruijnen S, Tsang-A-Sjoe M, Raterman H, Ramwadhdoebe T, Vugts D, van Dongen G, Huisman M, Hoekstra O, Tak PP, Voskuyl A, van der Laken C.

B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients.

Arthritis Res Ther. 2016 Nov 18;18(1):266. PMID:27863504

van Vollenhoven RF.

Who gets SLE? Clues to a tantalizing syndrome.

Arthritis Rheumatol. 2016 Nov 18. doi: 10.1002/art.40005. [Epub ahead of print] No abstract available. PMID:27863170

Biesbroek PS, Heslinga SC, Konings TC, van der Horst-Bruinsma IE, Hofman MB, van de Ven PM, Kamp O, van Halm VP, Peters MJ, Smulders YM, van Rossum AC, Nurmohamed MT, Nijveldt R.

Insights into cardiac involvement in ankylosing spondylitis from cardiovascular magnetic resonance.

Heart. 2016 Nov 16. pii: heartjnl-2016-310667. doi: 10.1136/heartjnl-2016-310667. [Epub ahead of print]. PMID:27852696

Bernelot Moens SJ, van Leuven SI, Zheng KH, Havik SR, Versloot MV, van Duivenvoorde LM, Hahne M, Stroes ES, Baeten DL, Hamers AA.

Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques.

PLoS One. 2016 Nov 7;11(11):e0164690. doi: 10.1371/journal.pone.0164690. PMID:27820817

Tang MW, Koopman FA, Visscher JP, de Hair MJ, Gerlag DM, Tak PP.

Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease.

Clin Rheumatol. 2016 Nov 2. [Epub ahead of print]. PMID:27807638

Heslinga M, Nurmohamed MT.

Cardiovascular Disease Reduction in Rheumatoid Arthritis by Statins: The Final Evidence?

J Rheumatol. 2016 Nov;43(11):1950-1952. No abstract available. PMID:27803339

October 2016

van Steenbergen HW, Aletaha D, Beaart-van de Voorde LJ, Brouwer E, Codreanu C, Combe B, Fonseca JE, Hetland ML, Humby F, Kvien TK, Niedermann K, Nuño L, Oliver S, Rantapää-Dahlqvist S, Raza K, van Schaardenburg D, Schett G, De Smet L, Szücs G, Vencovský J, Wiland P, de Wit M, Landewé RL, van der Helm-van Mil AH.

EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis.

Ann Rheum Dis. 2016 Oct 6. pii: annrheumdis-2016-209846. doi: 10.1136/annrheumdis-2016-209846. [Epub ahead of print].PMID:27991858

Castañeda S, Nurmohamed MT, González-Gay MA.

Cardiovascular disease in inflammatory rheumatic diseases.

Best Pract Res Clin Rheumatol. 2016 Oct;30(5):851-869. doi: 10.1016/j.berh.2016.10.006. Review. PMID:27964792

Matthijssen XM, Akdemir G, Markusse IM, Stijnen T, Riyazi N, Han KH, Bijkerk C, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Age affects joint space narrowing in patients with early active rheumatoid arthritis.

RMD Open. 2016 Oct 18;2(2):e000338. PMID:27843577

Landewé RB, van der Heijde DM.

Why CAPS criteria are not diagnostic criteria?

Ann Rheum Dis. 2016 Oct 31. pii: annrheumdis-2016-210656. doi: 10.1136/annrheumdis-2016-210656. [Epub ahead of print] No abstract available. PMID:27799158

Zerbini CA, Clark P, Mendez-Sanchez L, Pereira RM, Messina OD, Uña CR, Adachi JD, Lems WF, Cooper C, Lane NE; IOF Chronic Inflammation and Bone Structure (CIBS) Working Group.

Biologic therapies and bone loss in rheumatoid arthritis.

Osteoporos Int. 2016 Oct 31. [Epub ahead of print] Review. PMID:27796445

Cui J, Diogo D, Stahl EA, Canhao H, Mariette X, Greenberg JD, Okada Y, Pappas DA, Fulton RS, Tak PP, Nurmohamed MT, Lee A, Larson DE, Kurreeman F, Deluca TL, O’Laughlin M, Fronick CC, Fulton LL, Mardis ER, van der Horst-Bruinsma IE, Wolbink GJ, Gregersen PK, Kremer JM, Crusius JB, de Vries N, Huizinga TW, Fonseca JE, Miceli-Richard C, Karlson EW, Coenen MJ, Barton A, Plenge RM, Raychaudhuri S.

The role of rare protein-coding variants to anti-TNF treatment response in rheumatoid arthritis.

Arthritis Rheumatol. 2016 Oct 27. doi: 10.1002/art.39966. [Epub ahead of print] PMID:27788309

 

Paramarta JE, Turina MC, Noordenbos T, Heijda TF, Blijdorp IC, Yeremenko N, Baeten D.

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis.

J Transl Med. 2016 Oct 27;14(1):308. PMID:27784336

 

Tarp S, Furst DE, Dossing A, Østergaard M, Lorenzen T, Hansen MS, Singh JA, Choy EH, Boers M, Suarez-Almazor ME, Kristensen LE, Bliddal H, Christensen R.

Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials.

Semin Arthritis Rheum. 2016 Sep 14. pii: S0049-0172(16)30270-0. doi: 10.1016/j.semarthrit.2016.09.003. [Epub ahead of print] PMID:27769592

 

Bergstra SA, Machado PM, van den Berg R, Landewé RB, Huizinga TW.

Ten years of METEOR (an international rheumatoid arthritis registry): development, research opportunities and future perspectives.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 101(5):87-90. Review. PMID:27762201

Ludvigsson JF, van Vollenhoven R.

Prevalence and comorbidity of relapsing polychondritis.

Clin Epidemiol. 2016 Sep 30;8:361-362. No abstract available. PMID:27757051

Ogdie A, Taylor WJ, Neogi T, Fransen J, Jansen TL, Ralph Schumacher H, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Cagnotto G, Cavagna L, Lin C, Chou YY, Tausche AK, Lima Gomes Ochtrop M, Janssen M, Chen JH, Slot O, Lazovskis J, White D, Cimmino MA, Uhlig T, Dalbeth N.

Performance of Ultrasound in the Diagnosis of Gout in a Multi-Center Study: Comparison with Monosodium Urate Crystal Analysis as the Gold Standard.

Arthritis Rheumatol. 2016 Oct 16. doi: 10.1002/art.39959. [Epub ahead of print] PMID:27748084

 

Peter WF, Cw de Vet H, Boers M, Harlaar J, Roorda LD, Poolman RW, Ab Scholtes V, Steultjens M, Hendry GJ, Roos EM, Guillemin F, Benedetti MG, Cavazzuti L, Escobar A, Dagfinrud H, Terwee CB.

Cross-cultural and construct validity of the Animated Activity Questionnaire.

Arthritis Care Res (Hoboken). 2016 Oct 16. doi: 10.1002/acr.23127. [Epub ahead of print] PMID:27748072

Klokker L, Tugwell P, Furst DE, Devoe D, Williamson P, Terwee CB, Suarez-Almazor ME, Strand V, Woodworth T, Leong AL, Goel N, Boers M, Brooks PM, Simon LS, Christensen R.

Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.

J Rheumatol. 2016 Oct 15. pii: jrheum.161105. [Epub ahead of print] PMID:27744393

Lebre MC, Vieira PL, Tang MW, Aarrass S, Helder B, Newsom-Davis T, Tak PP, Screaton GR.

Synovial IL-21/TNF-producing CD4+ T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes.

J Leukoc Biol. 2016 Oct 12. pii: jlb.5A0516-217RR. [Epub ahead of print] PMID:27733582

van Schie KA, Kruithof S, van Schouwenburg PA, Vennegoor A, Killestein J, Wolbink G, Rispens T.

Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: the immune response to antibody therapeutics preferentially targets the antigen binding site.

J Allergy Clin Immunol. 2016 Oct 4. pii: S0091-6749(16)31086-7. doi: 10.1016/j.jaci.2016.09.014. [Epub ahead of print] PMID:27717666

Agca R, Nurmohamed MT.

Editorial commentary: The challenge to optimize cardiovascular disease risk management in patients with rheumatoid arthritis.

Trends Cardiovasc Med. 2016 Sep 7. pii: S1050-1738(16)30135-9. doi: 10.1016/j.tcm.2016.09.001. [Epub ahead of print] No abstract available. PMID:27717537

Turina MC, Landewé R, Baeten D.

Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA.

Expert Rev Clin Immunol. 2016 Oct 5. [Epub ahead of print] PMID:27705027

de Wit M, Kirwan JR, Tugwell P, Beaton D, Boers M, Brooks P, Collins S, Conaghan PG, D’Agostino MA, Hofstetter C, Hughes R, Leong A, Lyddiatt A, March L, May J, Montie P, Richards P, Simon LS, Singh JA, Strand V, Voshaar M, Bingham CO 3rd, Gossec L.
Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT).

Patient. 2016 Oct 5. [Epub ahead of print] PMID:27704486

Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT.

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Ann Rheum Dis. 2016 Oct 3. pii: annrheumdis-2016-209775. doi: 10.1136/annrheumdis-2016-209775. [Epub ahead of print] PMID:27697765

Konijn NP, van Tuyl LH, Boers M, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, van Schaardenburg D, Nurmohamed MT, Lems WF.

Short and sustained periods of ACR/EULAR remission predict good functional outcome, but do not predict good radiographic outcome in early rheumatoid arthritis patients with low overall damage progression.

Arthritis Care Res (Hoboken). 2016 Oct 1. doi: 10.1002/acr.23112. [Epub ahead of print] PMID:27696732

van Tok MN, Yeremenko NG, Teitsma CA, Kream BE, Knaup VL, Lories RJ, Baeten DL, van Duivenvoorde LM.

Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis.

PLoS One. 2016 Oct 3;11(10):e0163632. doi: 10.1371/journal.pone.0163632. PMID:27695067

September 2016

Akdemir G, Markusse IM, Goekoop-Ruiterman YP, Steup-Beekman GM, Grillet BA, Kerstens PJ,Lems WF, Huizinga TW, Allaart CF.

Rheumatologists’ adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.

Clin Rheumatol. 2016 Sep 28. [Epub ahead of print]. PMID:27680540

Lems WF, Baak MM, van Tuyl LH, Lodder MC, Dijkmans BA, Boers M.

One-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapy.

RMD Open. 2016 Sep 12;2(2):e000313. doi: 10.1136/rmdopen-2016-000313. eCollection 2016. PMID:27651928

Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R.

Off-label use of rituximab for systemic lupus erythematosus in Europe.

Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163. eCollection 2016. PMID:27651920

Ramwadhdoebe TH, Hähnlein J, Maijer KI, van Boven LJ, Gerlag DM, Tak PP, van Baarsen LG.

Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at-risk phase of autoantibody positive rheumatoid arthritis.

Eur J Immunol. 2016 Sep 20. doi: 10.1002/eji.201646393. [Epub ahead of print]. PMID:27645315

Rysnik O, McHugh K, van Duivenvoorde L, van Tok M, Taurog J, Kollnberger S, Baeten D, Bowness P.

Data showing non-conventional HLA-B27 expression in axial joints and gut tissue from B27 transgenic rats, and in frozen and paraffin-fixed synovial SpA tissue.

Data Brief. 2016 Aug 28;9:100-11. doi: 10.1016/j.dib.2016.08.046. eCollection 2016 Dec. PMID:27642616

van der Esch M, van der Leeden M, Roorda LD, Lems WF, Dekker J.

Predictors of self-reported knee instability among patients with knee osteoarthritis: results of the Amsterdam osteoarthritis cohort.

Clin Rheumatol. 2016 Sep 17. [Epub ahead of print]. PMID:27639405

Lübbers J, van Beers-Tas MH, Vosslamber S, Turk SA, de Ridder S, Mantel E, Wesseling JG, Reijm M, van Hoogstraten IM, Bijlsma JW, van Schaardenburg D, Bontkes HJ, Verweij CL.

Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients.

Arthritis Res Ther. 2016 Sep 14;18(1):205. doi: 10.1186/s13075-016-1102-2. PMID:27629388

Prinsen CA, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, Williamson PR, Terwee CB.

How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline.

Trials. 2016 Sep 13;17(1):449. doi: 10.1186/s13063-016-1555-2. PMID:27618914

Tang MW, Reedquist KA, Garcia S, Fernandez BM, Codullo V, Vieira-Sousa E, Goffin V, Reuwer AQ, Twickler MT, Gerlag DM, Tak PP.

The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation.

Rheumatology (Oxford). 2016 Sep 10. pii: kew316. [Epub ahead of print]. PMID:27616146

van Schie KA, Ooijevaar-de Heer P, Dijk L, Kruithof S, Wolbink G, Rispens T.

Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange.

Sci Rep. 2016 Sep 8;6:32747. doi: 10.1038/srep32747.PMID:27605058

Niewerth D, Kaspers GJ, Jansen G, van Meerloo J, Zweegman S, Jenkins G, Whitlock JA, Hunger SP, Lu X, Alonzo TA, van de Ven PM, Horton TM, Cloos J.

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy.

J Hematol Oncol. 2016 Sep 6;9(1):82. doi: 10.1186/s13045-016-0312-z. PMID:27599459

Abheiden CN, Blomjous BS, Kroese SJ, Bultink IE, Fritsch-Stork RD, Lely AT, de Boer MA, de Vries JI.
Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study.

Hypertens Pregnancy. 2016 Sep 6:1-12. [Epub ahead of print]. PMID:27599157

de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL.

Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis.

Arthritis Res Ther. 2016 Sep 1;18:196. doi: 10.1186/s13075-016-1093-z. PMID:27586785

August 2016

D’Agostino MA, Haavardsholm EA, van der Laken CJ.

Diagnosis and management of rheumatoid arthritis; What is the current role of established and new imaging techniques in clinical practice?

Best Pract Res Clin Rheumatol. 2016 Aug;30(4):586-607. doi: 10.1016/j.berh.2016.10.011. Review.PMID:27931956

Levitsky A, Wick MC, Möttönen T, Leirisalo-Repo M, Laasonen L, Korpela M, van Vollenhoven RF, Rantalaiho V.

Early treatment intensification induces favourable radiographic outcomes according to predicted versus observed radiographic progression in early rheumatoid arthritis: a subanalysis of the randomised FIN-RACo and NEO-RACo trials.

Clin Exp Rheumatol. 2016 Aug 31. [Epub ahead of print]. PMID:27607411

de Rooij M, van der Leeden M, Cheung J, van der Esch M, Häkkinen A, Haverkamp D, Roorda LD, Twisk J, Vollebregt J, Lems WF, Dekker J.

Efficacy of tailored exercise therapy on physical functioning in patients with knee osteoarthritis and comorbidity: A randomized controlled trial.

Arthritis Care Res (Hoboken). 2016 Aug 26. doi: 10.1002/acr.23013. [Epub ahead of print]. PMID:27563831

Sieberts SK, Zhu F, García-García J, Stahl E, Pratap A, Pandey G, Pappas D, Aguilar D, Anton B, Bonet J, Eksi R, Fornés O, Guney E, Li H, Marín MA, Panwar B, Planas-Iglesias J, Poglayen D, Cui J, Falcao AO, Suver C, Hoff B, Balagurusamy VS, Dillenberger D, Neto EC, Norman T, Aittokallio T, Ammad-Ud-Din M, Azencott CA, Bellón V, Boeva V, Bunte K, Chheda H, Cheng L, Corander J, Dumontier M, Goldenberg A, Gopalacharyulu P, Hajiloo M, Hidru D, Jaiswal A, Kaski S, Khalfaoui B, Khan SA, Kramer ER, Marttinen P, Mezlini AM, Molparia B, Pirinen M, Saarela J, Samwald M, Stoven V, Tang H, Tang J, Torkamani A, Vert JP, Wang B, Wang T, Wennerberg K, Wineinger NE, Xiao G, Xie Y, Yeung R, Zhan X, Zhao C; Members of the Rheumatoid Arthritis Challenge Consortium, Greenberg J, Kremer J, Michaud K, Barton A, Coenen M, Mariette X, Miceli C, Shadick N, Weinblatt M, de Vries N, Tak PP, Gerlag D, Huizinga TW, Kurreeman F, Allaart CF, Louis Bridges S Jr, Criswell L, Moreland L, Klareskog L, Saevarsdottir S, Padyukov L, Gregersen PK, Friend S, Plenge R, Stolovitzky G, Oliva B, Guan Y, Mangravite LM, Bridges SL, Criswell L, Moreland L, Klareskog L, Saevarsdottir S, Padyukov L, Gregersen PK, Friend S, Plenge R, Stolovitzky G, Oliva B, Guan Y, Mangravite LM.

Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.

Nat Commun. 2016 Aug 23;7:12460. doi: 10.1038/ncomms12460. PMID:27549343

Franke NE, Kaspers GL, Assaraf YG, van Meerloo J, Niewerth D, Kessler FL, Poddighe PJ, Kole J, Smeets SJ, Ylstra B, Bi C, Chng WJ, Horton TM, Menezes RX, Musters RJ, Zweegman S, Jansen G, Cloos J.

Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors.

Oncotarget. 2016 Aug 17. doi: 10.18632/oncotarget.11340. [Epub ahead of print]. PMID:27542283

Essers I, Boonen A, Busch M, van der Heijde D, Keszei AP, Landewé R, Ramiro S, van Tubergen A.
Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis.

Rheumatology (Oxford). 2016 Aug 12. pii: kew303. [Epub ahead of print].PMID:27520798

van den Hoek J, Roorda LD, Boshuizen HC, Tijhuis GJ, Dekker J, van den Bos GA, Nurmohamed MT.

Trend in and predictors for cardiovascular mortality in patients with rheumatoid arthritis over a period of 15 years: a prospective cohort study.

Clin Exp Rheumatol. 2016 Aug 2. [Epub ahead of print]. PMID:27494398

Essers I, Boonen A, Busch M, van der Heijde D, Keszei AP, Landewé R, Ramiro S, van Tubergen A.

Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis.

Rheumatology (Oxford). 2016 Aug 12. pii: kew303. [Epub ahead of print]. PMID:27520798

Oude Voshaar MA, Schenk O, Ten Klooster PM, Vonkeman HE, Bernelot Moens HJ, Boers M, van de Laar MA.

Further Simplification of the Simple Erosion Narrowing Score With Item Response Theory Methodology.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1206-10. doi: 10.1002/acr.22793. PMID:27444101

July 2016

de Jong TD, Lübbers J, Turk S, Vosslamber S, Mantel E, Bontkes HJ, van der Laken CJ, Bijlsma JW, van Schaardenburg D, Verweij CL.

The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes.

Arthritis Res Ther. 2016 Jul 13;18:165. doi: 10.1186/s13075-016-1065-3.PMID:27411379

Rodríguez-Carrio J, Hähnlein JS, Ramwadhdoebe TH, Semmelink JF, Choi IY, van Lienden KP, Maas M, Gerlag DM, Tak PP, Geijtenbeek TB, van Baarsen LG.

Altered Innate Lymphoid Cells subsets in human lymph node biopsies during the at risk and earliest phase of rheumatoid arthritis.

Arthritis Rheumatol. 2016 Jul 18. doi: 10.1002/art.39811. [Epub ahead of print]. PMID:27428460

van Brummelen EM, Ros W, Wolbink G, Beijnen JH, Schellens JH.

Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges.

Oncologist. 2016 Jul 20. pii: theoncologist.2016-0061. [Epub ahead of print] Review. PMID:27440064

Kneepkens EL, van den Oever I, Plasencia CH, Pascual-Salcedo D, de Vries A, Hart M, Nurmohamed MT, Balsa A, Rispens T, Wolbink G.

Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study.

Scand J Rheumatol. 2016 Jul 20:1-8. [Epub ahead of print].PMID:27440258

Angiolilli C, Kabala PA, Grabiec AM, Van Baarsen IM, Ferguson BS, García S, Malvar Fernandez B, McKinsey TA, Tak PP, Fossati G, Mascagni P, Baeten DL, Reedquist KA.

Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytes.

Ann Rheum Dis. 2016 Jul 25. pii: annrheumdis-2015-209064. doi: 10.1136/annrheumdis-2015-209064. [Epub ahead of print].PMID:27457515

Lesuis N, Verhoef LM, Nieboer LM, Bruyn GA, Baudoin P, van Vollenhoven RF, Hulscher M, van den Hoogen F, den Broeder AA.

Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.

Scand J Rheumatol. 2016 Jul 27:1-4. [Epub ahead of print].PMID:27460224

Lesuis N, den Broeder AA, van Vollenhoven RF, Vriezekolk JE, Hulscher M.

Choosing wisely in daily practice: a mixed methods study on determinants of antinuclear antibody testing by rheumatologists.

Scand J Rheumatol. 2016 Jul 29:1-6. [Epub ahead of print].PMID:27471798

Fleischmann RM, Huizinga TW, Kavanaugh AF, Wilkinson B, Kwok K, DeMasi R, van Vollenhoven RF.

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis.

RMD Open. 2016 Jul 26;2(2):e000262. doi: 10.1136/rmdopen-2016-000262. eCollection 2016. PMID:27493790

Baraliakos X, Heldmann F, van den Bosch F, Burmester G, Gaston H, van der Horst-Bruinsma IE, Krause A, Schmidt R, Schneider M, Sieper J, Andermann B, van Tubergen A, Witt M, Braun J.

Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction.

RMD Open. 2016 Jul 19;2(2):e000272. doi: 10.1136/rmdopen-2016-000272. eCollection 2016. PMID:27493791

Boers M.

Let’s stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!

Ann Rheum Dis. 2016 Jul 7. pii: annrheumdis-2016-210063. doi: 10.1136/annrheumdis-2016-210063. [Epub ahead of print] No abstract available. PMID:27390362

Deodhar A, Dougados M, Baeten D, Wei C, Geusens P, Readie A, Richards H, Martin R, Porter B.

Effect of secukinumab on patient-reported outcomes in patients with active ankylosing spondylitis: A Phase 3 randomized trial (MEASURE 1).

Arthritis Rheumatol. 2016 Jul 7. doi: 10.1002/art.39805. [Epub ahead of print] PMID:27390130

Koopman FA, Chavan SS, Miljko S, Grazio S, Sokolovic S, Schuurman PR, Mehta AD, Levine YA, Faltys M, Zitnik R, Tracey KJ, Tak PP.

Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis.

Proc Natl Acad Sci U S A. 2016 Jul 5. pii: 201605635. [Epub ahead of print] PMID:27382171

Kuijpers TW, Vendelbosch S, Berg Mv, Baeten DL.

Killer immunoglobulin receptor genes in spondyloarthritis.

Curr Opin Rheumatol. 2016 Jul;28(4):368-75. doi: 10.1097/BOR.0000000000000302. PMID:27166924

Smolen JS, Collaud Basset S, Boers M, Breedveld F, Edwards CJ, Kvien TK, Miossec P, Sokka-Isler T, van Vollenhoven RF, Abadie EC, Bruyère O, Cooper C, Mäkinen H, Thomas T, Tugwell P, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.

Ann Rheum Dis. 2016 Jul;75(7):1268-71. doi: 10.1136/annrheumdis-2016-209429. Epub 2016 Apr 1. Review. PMID:27037326

June 2016

Hua C, Audo R, Yeremenko N, Baeten D, Hahne M, Combe B, Morel J, Daïen C.

A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells.

J Autoimmun. 2016 Jun 29. pii: S0896-8411(16)30080-4. doi: 10.1016/j.jaut.2016.06.002. [Epub ahead of print] PMID:27372914

van Vollenhoven RF.

New therapeutic approaches in rheumatoid arthritis.

Presse Med. 2016 Jun;45(6 Pt 2):e179-92. doi: 10.1016/j.lpm.2016.05.004. Epub 2016 May 27. PMID:27242206

Lensen KD, Voskuyl AE, Comans EF, van der Laken CJ, Smulders YM.

Extracranial giant cell arteritis: A narrative review.

Neth J Med. 2016 Jun;74(5):182-92.PMID:27323671

Genovese MC, van Vollenhoven RF, Wilkinson B, Wang L, Zwillich SH, Gruben D, Biswas P, Riese R, Takiya L, Jones TV.

Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis.

Arthritis Res Ther. 2016 Jun 23;18:145. doi: 10.1186/s13075-016-1049-3. PMID:27334658

Quattrocchi E, Østergaard M, Taylor PC, van Vollenhoven RF, Chu M, Mallett S, Perry H, Kurrasch R.

Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.

PLoS One. 2016 Jun 23;11(6):e0157961. doi: 10.1371/journal.pone.0157961. eCollection 2016. PMID:27336685

Boers M, Aletaha D, Mela CM, Baker DG, Smolen JS.

Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials.

J Rheumatol. 2016 Jun;43(6):1024-6. doi: 10.3899/jrheum.150932. Epub 2016 Apr 1.PMID:27036379

Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M, Dasgupta B, Dixon WG, Geenen R, Huizinga TW, Kent A, de Thurah AL, Listing J, Mariette X, Ray DW, Scherer HU, Seror R, Spies CM, Tarp S, Wiek D, Winthrop KL, Buttgereit F.

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.

Ann Rheum Dis. 2016 Jun;75(6):952-7. doi: 10.1136/annrheumdis-2015-208916. Epub 2016 Mar 1. Review. PMID:26933146

May 2016

Turina MC, de Winter JJ, Paramarta JE, Gamala M, Yeremenko N, Nabibux MN, Landewé R, Baeten DL.

Clinical and imaging signs of spondyloarthritis in first-degree relatives of HLA-B27 positive ankylosing spondylitis patients: The pre-spondyloarthritis (Pre-SpA) cohort.

Arthritis Rheumatol. 2016 May 23. doi: 10.1002/art.39766. [Epub ahead of print]PMID:27214232

Plasencia C, Wolbink G, Krieckaert CL, Kneepkens EL, Turk S, Jurado T, Martínez-Feito A, Navarro-Compán V, Bonilla G, Villalba A, Peiteado D, Nuño L, Martín-Mola E, Nurmohamed MT, van der Kleij D, Rispens T, Pascual-Salcedo D, Balsa A.

Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.

Clin Exp Rheumatol. 2016 May 19. [Epub ahead of print]PMID:27214767

D’Agostino MA, Boers M, Wakefield RJ, Berner Hammer H, Vittecoq O, Filippou G, Balint P, Möller I, Iagnocco A, Naredo E, Østergaard M, Gaillez C, Le Bars M.

Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study.

RMD Open. 2016 May 5;2(1):e000237. doi: 10.1136/rmdopen-2015-000237. eCollection 2016. PMID:27175297

Sanders JS, de Joode AA, DeSevaux RG, Broekroelofs J, Voskuyl AE, van Paassen P, Kallenberg CG, Tervaert JW, Stegeman CA.

Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.

Nephrol Dial Transplant. 2016 May 30. pii: gfw211. [Epub ahead of print] PMID:27242368

Maharaj AB, Rajkaran M, Govender J, Maharaj K, De Vries N, Tak PP.

Psoriatic arthritis: An assessment of clinical, biochemical and radiological features in a single-centre South African cohort.

S Afr Med J. 2016 May 5;106(6):630-3. doi: 10.7196/SAMJ.2016.v106i6.10347. PMID:27245733

Konijn NP, van Tuyl LH, Boers M, van de Ven PM, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, van Schaardenburg D, Lems WF, Nurmohamed MT.

The short-term effects of two high-dose, step-down prednisolone regimens on body composition in early rheumatoid arthritis.

Rheumatology (Oxford). 2016 May 31. pii: kew221. [Epub ahead of print] PMID:27247434

Lesuis N, den Broeder AA, Hulscher ME, van Vollenhoven RF.

Practice what you preach? An exploratory multilevel study on rheumatoid arthritis guideline adherence by rheumatologists.

RMD Open. 2016 May 17;2(1):e000195. doi: 10.1136/rmdopen-2015-000195. eCollection 2016. PMID:27252892

Rubbert-Roth A, Sebba A, Brockwell L, Kelman A, Porter-Brown B, Pulley J, Napalkov P, van Vollenhoven RF.

Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab.

RMD Open. 2016 May 10;2(1):e000213. doi: 10.1136/rmdopen-2015-000213. eCollection 2016. PMID:27252893

Bernelot Moens SJ, van der Valk FM, Strang AC, Kroon J, Smits LP, Kneepkens EL, Verberne HJ, van Buul JD, Nurmohamed MT, Stroes ES.

Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study.

Arthritis Res Ther. 2016 May 21;18(1):115. doi: 10.1186/s13075-016-1008-z.PMID:27209093

Koeckhoven E, van der Leeden M, Roorda LD, van Schoor NM, Lips P, de Zwart A, Dekker J, van der Esch M, Lems WF.

The Association Between Serum 25-hydroxy Vitamin D Level and Upper Leg Strength in Patients with Knee Osteoarthritis: Results of the Amsterdam Osteoarthritis Cohort.

J Rheumatol. 2016 May 15. pii: jrheum.150751. [Epub ahead of print] PMID:27182064

D’Agostino MA, Boers M, Wakefield RJ, Berner Hammer H, Vittecoq O, Filippou G, Balint P, Möller I, Iagnocco A, Naredo E, Østergaard M, Gaillez C, Le Bars M.

Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE study.

RMD Open. 2016 May 5;2(1):e000237. doi: 10.1136/rmdopen-2015-000237. eCollection 2016. PMID:27175297

Ekholm L, Vosslamber S, Tjärnlund A, de Jong T, Betteridge Z, McHugh N, Plestilova L, Klein M, Padyukov L, Voskuyl AE, Bultink IE, Pegtel DM, Mavragani CP, Crow MK, Vencovsky J, Lundberg IE, Verweij CL.

Autoantibody specificities and type I interferon pathway activation in Idiopathic Inflammatory Myopathies.

Scand J Immunol. 2016 May 13. doi: 10.1111/sji.12449. [Epub ahead of print]PMID:27173897

van Tuyl LH, Michaud K.

Patient-Reported Outcomes in Rheumatoid Arthritis.

Rheum Dis Clin North Am. 2016 May;42(2):219-37. doi: 10.1016/j.rdc.2016.01.010. Epub 2016 Mar 17. Review. PMID:27133486

Chemin K, Pollastro S, James E, Ge C, Albrecht I, Herrath J, Gerstner C, Tandre K, Sampaio Rizzi T, Rönnblom L, Catrina A, Holmdahl R, Klareskog L, de Vries N, Malmström V.
A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid Arthritis.

Arthritis Rheumatol. 2016 May;68(5):1124-35. doi: 10.1002/art.39553. PMID:26713667

Landewé R, van der Heijde D.

New concepts of clinical trials in rheumatoid arthritis: a boom of noninferiority trials.

Curr Opin Rheumatol. 2016 May;28(3):316-22. doi: 10.1097/BOR.0000000000000280. PMID: 26989909

López-Isac E, Martín JE, Assassi S, Simeón CP, Carreira P, Ortego-Centeno N, Freire M, Beltrán E, Narváez J, Alegre-Sancho JJ; Spanish Scleroderma Group, Fernández-Gutiérrez B, Balsa A, Ortiz AM, González-Gay MA, Beretta L, Santaniello A, Bellocchi C, Lunardi C, Moroncini G, Gabrielli A, Witte T, Hunzelmann N, Distler JH, Riekemasten G, van der Helm-van Mil AH, de Vries-Bouwstra J, Magro-Checa C, Voskuyl AE, Vonk MC, Molberg Ø, Merriman T, Hesselstrand R, Nordin A, Padyukov L, Herrick A, Eyre S, Koeleman BP, Denton CP, Fonseca C, Radstake TR, Worthington J, Mayes MD, Martín J.

Cross-disease Meta-analysis of Genome-wide Association Studies for Systemic Sclerosis and Rheumatoid Arthritis Reveals IRF4 as a New Common Susceptibility Locus.

Arthritis Rheumatol. 2016 Apr 25. doi: 10.1002/art.39730. [Epub ahead of print] PMID:27111665

Malysheva K, de Rooij K, Lowik CW, Baeten DL, Rose-John S, Stoika R, Korchynskyi O.

Interleukin 6/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts.

Croat Med J. 2016 Apr 23;57(2):89-98.PMID:27106351

Moots RJ, Balsa A, Wolbink G.

Reporting of potential immunogenicity with biologic drugs: clarity and accuracy required.

Ann Rheum Dis. 2016 May;75(5):e24. doi: 10.1136/annrheumdis-2016-209178. Epub 2016 Feb 4. No abstract available. PMID: 26847822

Navarro-Compán V, Ramiro S, Landewé R, Dougados M, Miceli-Richard C, Richette P, van der Heijde D.

Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.

Ann Rheum Dis. 2016 May;75(5):874-8. doi: 10.1136/annrheumdis-2015-207786. Epub 2015 Sep 24.

PMID: 26403689

Rekers NV, Bajema IM, Mallat MJ, Petersen B, Anholts JD, Swings GM, van Miert PP, Kerkhoff C, Roth J, Popp D, van Groningen MC, Baeten D, Goemaere N, Kraaij MD, Zandbergen M, Heidt S, van Kooten C, de Fijter JW, Claas FH, Eikmans M.

Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection.

Am J Transplant. 2016 May;16(5):1441-55. doi: 10.1111/ajt.13634. Epub 2016 Feb 1.PMID:26607974

Rovin B, van Vollenhoven R, Aranow C, Wagner C, Gordon R, Zhuang Y, Belkowski S, Hsu B.

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of treatment with sirukumab (CNTO 136) in patients with active lupus nephritis.

Arthritis Rheumatol. 2016 Apr 25. doi: 10.1002/art.39722. [Epub ahead of print] PMID:2711069

Smith V, Beeckman S, Herrick AL, Decuman S, Deschepper E, De Keyser F, Distler O, Foeldvari I, Ingegnoli F, Müller-Ladner U, Riccieri V, Riemekasten G, Sulli A, Voskuyl A, Cutolo M; EULAR study group on microcirculation.

An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases.

Rheumatology (Oxford). 2016 May;55(5):883-90. doi: 10.1093/rheumatology/kev441. Epub 2016 Feb 3. PMID: 26843483

Tsang-A-Sjoe MW, Nagelkerke SQ, Bultink IE, Geissler J, Tanck MW, Tacke CE, Ellis JA, Zenz W, Bijl M, Berden JH, de Leeuw K, Derksen RH, Kuijpers TW, Voskuyl AE.

Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis.

Rheumatology (Oxford). 2016 May;55(5):939-48. doi: 10.1093/rheumatology/kev433. Epub 2016 Jan 8. PMID:26748351

van de Glind EM, Willems HC, Eslami S, Abu-Hanna A, Lems WF, Hooft L, de Rooij SE, Black DM, van Munster BC.

Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate.

Drugs Aging. 2016 May;33(5):347-53. doi: 10.1007/s40266-016-0344-7. PMID:26884390

van Tuyl LH, Michaud K.

Patient-Reported Outcomes in Rheumatoid Arthritis.

Rheum Dis Clin North Am. 2016 May;42(2):219-37. doi: 10.1016/j.rdc.2016.01.010. Epub 2016 Mar 17. Review. PMID: 27133486

van Vilsteren M, Boot CR, Twisk JW, van Schaardenburg D, Steenbeek R, Voskuyl AE, Anema JR.

Effectiveness of an integrated care intervention on supervisor support and work functioning of workers with rheumatoid arthritis.

Disabil Rehabil. 2016 Apr 21:1-9. [Epub ahead of print] PMID:27097657

April 2016

Koopman FA, Tang MW, Vermeij J, de Hair MJ, Choi IY, Vervoordeldonk MJ, Gerlag DM, Karemaker JM, Tak PP.

Autonomic Dysfunction Precedes Development of Rheumatoid Arthritis: A Prospective Cohort Study.

EBioMedicine. 2016 Apr;6:231-7. doi: 10.1016/j.ebiom.2016.02.029. Epub 2016 Feb 19. PMID:27211565

Ramwadhdoebe TH, Hähnlein J, van Kuijk BJ, Choi IY, van Boven LJ, Gerlag DM, Tak PP, van Baarsen LG.

Human lymph-node CD8(+) T cells display an altered phenotype during systemic autoimmunity.

Clin Transl Immunology. 2016 Apr 1;5(4):e67. doi: 10.1038/cti.2016.8. eCollection 2016 Apr. PMID:27195110

Boers M, Aletaha D, Mela CM, Baker DG, Smolen JS.

Glucocorticoid Effect on Radiographic Progression in Placebo Arms of Rheumatoid Arthritis Biologics Trials.

J Rheumatol. 2016 Apr 1. pii: jrheum.150932. [Epub ahead of print] PMID: 27036379

de Rooij M, van der Leeden M, Heymans MW, Holla JF, Häkkinen A, Lems WF, Roorda LD, Veenhof C, Sanchez-Ramirez DC, de Vet HC, Dekker J.

Prognosis of Pain and Physical Functioning in Patients With Knee Osteoarthritis: A Systematic Review and Meta-Analysis.

Arthritis Care Res (Hoboken). 2016 Apr;68(4):481-92. doi: 10.1002/acr.22693. PMID: 26316234

Kahl L, Patel J, Layton M, Binks M, Hicks K, Leon G, Hachulla E, Machado D, Staumont-Sallé D, Dickson M, Condreay L, Schifano L, Zamuner S, van Vollenhoven RF; JAK115919 Study Team.

Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.

Lupus. 2016 Apr 6. pii: 0961203316640910. [Epub ahead of print] PMID: 27055521

Lesuis N, Hulscher ME, Piek E, Demirel H, van der Laan-Baalbergen N, Meek I, van Vollenhoven RF, den Broeder AA.

Choosing Wisely in Daily Practice: An Intervention Study on Antinuclear Antibody Testing by Rheumatologists.

Arthritis Care Res (Hoboken). 2016 Apr;68(4):562-9. doi: 10.1002/acr.22725. PMID: 26414008

Markusse IM, Akdemir G, Dirven L, Goekoop-Ruiterman YP, van Groenendael JH, Han KH, Molenaar TH, Le Cessie S, Lems WF, van der Lubbe PA, Kerstens PJ, Peeters AJ, Ronday HK, de Sonnaville PB, Speyer I, Stijnen T, Ten Wolde S, Huizinga TW, Allaart CF.

Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial.

Ann Intern Med. 2016 Apr 19;164(8):523-31. doi: 10.7326/M15-0919. Epub 2016 Mar 1.

PMID: 27089068

Markusse IM, Dirven L, Han KH, Ronday HK, de Sonnaville PB, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.

Arthritis Care Res (Hoboken). 2016 Apr;68(4):446-53. doi: 10.1002/acr.22681. PMID: 26239288

Pathak JL, Verschueren P, Lems WF, Bravenboer N, Klein-Nulend J, Bakker AD, Luyten FP.

Serum of patients with active rheumatoid arthritis inhibits differentiation of osteochondrogenic precursor cells.

Connect Tissue Res. 2016 Apr 6:1-11. [Epub ahead of print] PMID: 27050327

Smolen JS, Collaud Basset S, Boers M, Breedveld F, Edwards CJ, Kvien TK, Miossec P, Sokka-Isler T, van Vollenhoven RF, Abadie EC, Bruyère O, Cooper C, Mäkinen H, Thomas T, Tugwell P, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.

Ann Rheum Dis. 2016 Apr 1. pii: annrheumdis-2016-209429. doi: 10.1136/annrheumdis-2016-209429. [Epub ahead of print] Review. PMID: 27037326

van Beers-Tas MH, Marotta A, Boers M, Maksymowych WP, van Schaardenburg D.

A prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgia.

Arthritis Res Ther. 2016 Apr 1;18(1):76. doi: 10.1186/s13075-016-0975-4. PMID: 27037016

van den Oever IA, van Sijl AM, Baylan U, Ter Wee MM, Schalkwijk CG, Krijnen PA, Nurmohamed MT, Voskuyl AE, Niessen HW, Simsek S.

Comparing inflammatory cell density in the myocardium and coronary arteries in rheumatoid arthritis patients versus controls with myocardial infarction: A post-mortem case-control study.

Int J Cardiol. 2016 Apr 15;209:74-6. doi: 10.1016/j.ijcard.2016.02.065. Epub 2016 Feb 3. No abstract available. PMID: 26882189

van der Valk FM, Bernelot Moens SJ, Verweij SL, Strang AC, Nederveen AJ, Verberne HJ, Nurmohamed MT, Baeten DL, Stroes ES.

Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy.

Ann Rheum Dis. 2016 Apr 15. pii: annrheumdis-2016-209176. doi: 10.1136/annrheumdis-2016-209176. [Epub ahead of print] PMID: 27084958

van de Sande MG, Baeten DL.

Immunopathology of synovitis: from histology to molecular pathways.

Rheumatology (Oxford). 2016 Apr;55(4):599-606. doi: 10.1093/rheumatology/kev330. Epub 2015 Sep 10. Review. PMID: 26359330

van der Weijden MA, van Vugt LM, Valk D, Wisselink W, van Vugt RM, Voskuyl AE, Lems WF.

Exploring thermography: a promising tool in differentiation between infection and ischemia of the acra in systemic sclerosis.

Int J Rheum Dis. 2016 Apr 2. doi: 10.1111/1756-185X.12859. [Epub ahead of print] No abstract available. PMID: 27038005

van der Weijden MA, van Denderen JC, Lems WF, Nurmohamed MT, Dijkmans BA, van der Horst-Bruinsma IE.

Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.

J Rheumatol. 2016 Apr;43(4):758-64. doi: 10.3899/jrheum.150857. Epub 2016 Feb 15. PMID: 26879348

van Vilsteren M, Boot CR, Twisk JW, Steenbeek R, Voskuyl AE, van Schaardenburg D, Anema JR.

One Year Effects of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis: Results of a Randomized Controlled Trial.

J Occup Rehabil. 2016 Apr 7. [Epub ahead of print] PMID: 27056549

Wojtuszkiewicz A, Assaraf YG, Hoekstra M, Sciarrillo R, Jansen G, Peters GJ, Pieters R, Sonneveld E, Escherich G, Kaspers GJ, Cloos J.

The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia.

Haematologica. 2016 Apr 1. pii: haematol.2016.142794. [Epub ahead of print] PMID: 27036162

Wojtuszkiewicz A, Raz S, Stark M, Assaraf YG, Jansen G, Peters GJ, Sonneveld E, Kaspers GJ, Cloos J.

Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance.

Int J Cancer. 2016 Apr 1;138(7):1645-56. doi: 10.1002/ijc.29919. Epub 2015 Nov 25. PMID: 26547381

Wojtuszkiewicz A, Schuurhuis GJ, Kessler FL, Piersma SR, Knol JC, Pham TV, Jansen G, Musters RJ, van Meerloo J, Assaraf YG, Kaspers GJ, Zweegman S, Cloos J, Jimenez CR.

Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis.

Mol Cell Proteomics. 2016 Apr;15(4):1281-98. doi: 10.1074/mcp.M115.052944. Epub 2016 Jan 22. PMID: 26801919

March 2016

Akdemir G, Markusse IM, Dirven L, Riyazi N, Steup-Beekman GM, Kerstens P, Lems WF, Huizinga T, Allaart CF.

Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial.

RMD Open. 2016 Mar 25;2(1):e000143. doi: 10.1136/rmdopen-2015-000143. eCollection 2016. PMID:27099776

Bultink IE, Lems WF.

Lupus and fractures.

Curr Opin Rheumatol. 2016 Mar 14. [Epub ahead of print] PMID: 26978130

Baillet A, Gossec L, Carmona L, Wit M, van Eijk-Hustings Y, Bertheussen H, Alison K, Toft M, Kouloumas M, Ferreira RJ, Oliver S, Rubbert-Roth A, van Assen S, Dixon WG, Finckh A, Zink A, Kremer J, Kvien TK, Nurmohamed M, van der Heijde D, Dougados M.

Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative.

Ann Rheum Dis. 2016 Mar 16. pii: annrheumdis-2016-209233. doi: 10.1136/annrheumdis-2016-209233. [Epub ahead of print] PMID: 26984008

Chemin K, Pollastro S, Albrecht I, Holmdahl R, de Vries N, Malmström V.

RA-relevant T cell responses to type II collagen can be influenced by post-translational modifications.

Arthritis Rheumatol. 2016 Mar 4. doi: 10.1002/art.39660. [Epub ahead of print] No abstract available. PMID: 26945919

Dalbeth N, Schumacher HR, Fransen J, Neogi T, Jansen TL, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Cimmino MA, Uhlig T, Taylor WJ.

Survey definitions of gout for epidemiological studies: Comparison with crystal identification as the gold standard.

Arthritis Care Res (Hoboken). 2016 Mar 25. doi: 10.1002/acr.22896. [Epub ahead of print] PMID: 27014846

de Rooij M, van der Leeden M, Heymans MW, Holla JF, Häkkinen A, Lems WF, Roorda LD, Veenhof C, Sanchez-Ramirez DC, de Vet HC, Dekker J.

Course and predictors of pain and physical functioning in patients with hip osteoarthritis: Systematic review and meta-analysis.

J Rehabil Med. 2016 Mar 1;48(3):245-52. doi: 10.2340/16501977-2057. PMID: 26871564

Doorenspleet ME, Hubers LM, Culver EL, Maillette de Buy Wenniger LJ, Klarenbeek PL, Chapman RW, Baas F, van de Graaf SF, Verheij J, van Gulik TM, Barnes E, Beuers U, de Vries N.

IgG4+ B-Cell Receptor Clones Distinguish IgG4-Related Disease from Primary Sclerosing Cholangitis and Biliary/Pancreatic Malignancies.

Hepatology. 2016 Mar 25. doi: 10.1002/hep.28568. [Epub ahead of print] PMID: 27015613

Eriksson JK, Wallman JK, Miller H, Petersson IF, Ernestam S, Vivar N, van Vollenhoven RF, Neovius M.

Infliximab versus Conventional Combination Treatment and 7-Year Work Loss in Early RA: Results of the Randomized Swefot Trial.

Arthritis Care Res (Hoboken). 2016 Mar 25. doi: 10.1002/acr.22899. [Epub ahead of print] PMID: 27015295

Essers I, Ramiro S, Stolwijk C, Blaauw M, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A.

Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASIS.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):214-21. Epub 2016 Feb 2. PMID: 26843505

Evstigneeva L, Lesnyak O, Bultink IE, Lems WF, Kozhemyakina E, Negodaeva E, Guselnikova G, Belkin A.

Effect of twelve-month physical exercise program on patients with osteoporotic vertebral fractures: a randomized, controlled trial.

Osteoporos Int. 2016 Mar 16. [Epub ahead of print] PMID: 26984569

Garcia S, Hartkamp LM, Malvar-Fernandez B, van Es IE, Lin H, Wong J, Long L, Zanghi JA, Rankin AL, Masteller EL, Wong BR, Radstake TR, Tak PP, Reedquist KA.

Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis.

Arthritis Res Ther. 2016 Mar 31;18(1):75. doi: 10.1186/s13075-016-0973-6. PMID: 27036883

Gherghe AM, Ramiro S, Landewé R, Mihai C, van der Heijde D.

Association of the different types of radiographic damage with physical function in patients with rheumatoid arthritis: analysis of the RAPID trials.

RMD Open. 2016 Mar 11;2(1):e000219. doi: 10.1136/rmdopen-2015-000219. eCollection 2016. PMID: 27042337

Hambardzumyan K, Bolce RJ, Saevarsdottir S, Forslind K, Wallman JK, Cruickshank SE, Sasso EH, Chernoff D, van Vollenhoven RF.

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

RMD Open. 2016 Mar 1;2(1):e000197. doi: 10.1136/rmdopen-2015-000197. eCollection 2016. PMID: 26958364

Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Sam Lim S, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V.

A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.

Arthritis Rheumatol. 2016 Mar 18. doi: 10.1002/art.39674. [Epub ahead of print] PMID: 26991067

Heldmann F, Baraliakos X, Kiltz U, Brandt J, van der Horst-Bruinsma IE, Landewé R, Sieper J, Burmester GR, van den Bosch F, de Vlam K, Gaston H, Gruenke M, Witt M, Appelboom T, Emery P, Dougados M, Leirisalo-Repo M, Breban M, Braun J.

Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):184-90. Epub 2016 Mar 25. PMID: 27049733

Kroon FP, van der Burg LR, Ramiro S, Landewé RB, Buchbinder R, Falzon L, van der Heijde D.

Nonsteroidal Antiinflammatory Drugs for Axial Spondyloarthritis: A Cochrane Review.

J Rheumatol. 2016 Mar;43(3):607-17. doi: 10.3899/jrheum.150721. Epub 2016 Feb 1. PMID: 26834216

Maijer KI, van der Leij C, de Hair MJ, Tas SW, Maas M, Gerlag DM, Tak PP, Lavini C.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Pharmacokinetic Modeling: Initial Experience in Patients With Early Arthritis.

Arthritis Rheumatol. 2016 Mar;68(3):587-96. doi: 10.1002/art.39469. PMID: 26473331

Marsman G, Stephan F, de Leeuw K, Bulder I, Ruinard JT, de Jong J, Westra J, Bultink IE, Voskuyl AE, Aarden LA, Luken BM, Kallenberg CG, Zeerleder S.

FSAP-mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE.

Eur J Immunol. 2016 Mar;46(3):762-71. doi: 10.1002/eji.201546010. Epub 2015 Dec 22. PMID: 26626052

Noordenbos T, Blijdorp I, Chen S, Stap J, Mul E, Cañete JD, Lubberts E, Yeremenko N, Baeten D.

Human mast cells capture, store, and release bioactive, exogenous IL-17A.

J Leukoc Biol. 2016 Mar 31. pii: jlb.3HI1215-542R. [Epub ahead of print] PMID: 27034403

Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Peichl P, Pavelka K, Chartier M, Poncet C, Rauch C, Le Bars M.

Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.

Clin Exp Rheumatol. 2016 Mar 10. [Epub ahead of print] PMID: 26966919

Putrik P, Ramiro S, Lie E, Keszei AP, Kvien TK, van der Heijde D, Landewé R, Uhlig T, Boonen A.

Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD.

Rheumatology (Oxford). 2016 Mar 24. pii: kew048. [Epub ahead of print] PMID: 27012686

Rombouts Y, Willemze A, van Beers JJ, Shi J, Kerkman PF, van Toorn L, Janssen GM, Zaldumbide A, Hoeben RC, Pruijn GJ, Deelder AM, Wolbink G, Rispens T, van Veelen PA, Huizinga TW, Wuhrer M, Trouw LA, Scherer HU, Toes RE.

Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

Ann Rheum Dis. 2016 Mar;75(3):578-85. doi: 10.1136/annrheumdis-2014-206598. Epub 2015 Jan 13. PMID: 25587188

Rysnik O, McHugh K, van Duivenvoorde L, van Tok M, Guggino G, Taurog J, Kollnberger S, Ciccia F, Baeten D, Bowness P.

Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.

J Autoimmun. 2016 Mar 29. pii: S0896-8411(16)30022-1. doi: 10.1016/j.jaut.2016.03.009. [Epub ahead of print] PMID: 27036372

Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M, Dasgupta B, Dixon WG, Geenen R, Huizinga TW, Kent A, de Thurah AL, Listing J, Mariette X, Ray DW, Scherer HU, Seror R, Spies CM, Tarp S, Wiek D, Winthrop KL, Buttgereit F.

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.

Ann Rheum Dis. 2016 Mar 1. pii: annrheumdis-2015-208916. doi: 10.1136/annrheumdis-2015-208916. [Epub ahead of print] Review. PMID: 26933146

Tenten-Diepenmaat M, Dekker J, Steenbergen M, Huybrechts E, Roorda LD, van Schaardenburg D, Bus SA, van der Leeden M.

In-shoe plantar pressure measurements for the evaluation and adaptation of foot orthoses in patients with rheumatoid arthritis: A proof of concept study.

Gait Posture. 2016 Mar;45:45-50. doi: 10.1016/j.gaitpost.2015.12.039. Epub 2015 Dec 29. PMID: 26979882

van Onna M, Ten Cate DF, Tsoi KL, Meier AJ, Jacobs JW, Westgeest AA, Meijer PB, van Beek MC, Rensen WH, Bijlsma JW.

Assessment of disease activity in patients with rheumatoid arthritis using optical spectral transmission measurements, a non-invasive imaging technique.

Ann Rheum Dis. 2016 Mar;75(3):511-8. doi: 10.1136/annrheumdis-2015-207315. Epub 2015 Oct 9. PMID: 26452538

van Tunen JA, van der Leeden M, Bos WH, Cheung J, van der Esch M, Gerritsen M, Peter WF, Roorda LD, Tijhuis GJ, Voorneman RE, Lems WF, Dekker J.

Optimization of Analgesics for Greater Exercise Therapy Participation Among Patients With Knee Osteoarthritis and Severe Pain: A Feasibility Study.

Arthritis Care Res (Hoboken). 2016 Mar;68(3):332-40. doi: 10.1002/acr.22682. PMID: 26239403

van Vollenhoven R.

Rheumatoid arthritis: Missed opportunities in the 2015 ACR guideline for RA treatment.

Nat Rev Rheumatol. 2016 Mar;12(3):135-6. doi: 10.1038/nrrheum.2015.181. Epub 2016 Jan 14. No abstract available. PMID: 26763731

van Vollenhoven RF, Petri M, Wallace DJ, Roth D, Molta CT, Hammer AE, Tang Y, Thompson A.

Cumulative corticosteroids over 52 weeks in patients with systemic lupus erythematosus: Pooled analyses from the phase III belimumab trials.

Arthritis Rheumatol. 2016 Mar 18. doi: 10.1002/art.39682. [Epub ahead of print] PMID: 26992106

February 2016

Reginster JY, Cooper C, Rizzoli R, Kanis JA, Appelboom G, Bautmans I, Bischoff-Ferrari HA, Boers M, Brandi ML, Bruyère O, Cherubini A, Flamion B, Fielding RA, Gasparik AI, Van Loon L, McCloskey E, Mitlak BH, Pilotto A, Reiter-Niesert S, Rolland Y, Tsouderos Y, Visser M, Cruz-Jentoft AJ.

Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia.

Aging Clin Exp Res. 2016 Feb;28(1):47-58. doi: 10.1007/s40520-015-0517-y. Epub 2015 Dec 30. PMID:26717937

Crins MH, Roorda LD, Smits N, de Vet HC, Westhovens R, Cella D, Cook KF, Revicki D, van Leeuwen J, Boers M, Dekker J, Terwee CB.

Calibration of the Dutch-Flemish PROMIS Pain Behavior item bank in patients with chronic pain.

Eur J Pain. 2016 Feb;20(2):284-96. doi: 10.1002/ejp.727. Epub 2015 May 26. PMID:2601433

Wesseling J, Boers M, Viergever MA, Hilberdink WK, Lafeber FP, Dekker J, Bijlsma JW.

Cohort Profile: Cohort Hip and Cohort Knee (CHECK) study.

Int J Epidemiol. 2016 Feb;45(1):36-44. doi: 10.1093/ije/dyu177. Epub 2014 Aug 29. PMID:25172137

Agca R, Heslinga SC, van Halm VP, Nurmohamed MT.

Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders.

Heart. 2016 Feb 17. pii: heartjnl-2015-307838. doi: 10.1136/heartjnl-2015-307838. [Epub ahead of print] Review. PMID: 26888573

Alten R, Nüßlein H, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Pavelka K, Chartier M, Poncet C, Rauch C, Elbez Y, Le Bars M.

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study.

RMD Open. 2016 Feb 15;2(1):e000228. doi: 10.1136/rmdopen-2015-000228. eCollection 2016. PMID: 26925253

Angiolilli C, Grabiec AM, Ferguson BS, Ospelt C, Malvar Fernandez B, van Es IE, van Baarsen LG, Gay S, McKinsey TA, Tak PP, Baeten DL, Reedquist KA.

Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression.

Ann Rheum Dis. 2016 Feb;75(2):430-8. doi: 10.1136/annrheumdis-2014-205635. Epub 2014 Dec 1. PMID: 25452308

Baglio SR, van Eijndhoven MA, Koppers-Lalic D, Berenguer J, Lougheed SM, Gibbs S, Léveillé N, Rinkel RN, Hopmans ES, Swaminathan S, Verkuijlen SA, Scheffer GL, van Kuppeveld FJ, de Gruijl TD, Bultink IE, Jordanova ES, Hackenberg M, Piersma SR, Knol JC, Voskuyl AE, Wurdinger T, Jiménez CR, Middeldorp JM, Pegtel DM.

Sensing of latent EBV infection through exosomal transfer of 5’pppRNA.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):E587-96. doi: 10.1073/pnas.1518130113. Epub 2016 Jan 14. PMID: 26768848

Baraliakos X, Borah B, Braun J, Baeten D, Laurent D, Sieper J, Emery P, McInnes IB, van Laar JM, Wordsworth P, Wollenhaupt J, Kellner H, Colin L, Vandenhende F, Radford K, Hueber W.

Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study.

Ann Rheum Dis. 2016 Feb;75(2):408-12. doi: 10.1136/annrheumdis-2015-207544. Epub 2015 Aug 6. PMID: 26248638

Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Ancuta I, Pavelka K, Nordström DC, Gabay C, Canhão H, Tomsic M, van Riel PL, Gomez-Reino J, Kvien TK, van Vollenhoven RF; Rheumatic Diseases Portuguese Register.

Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration.

Arthritis Res Ther. 2016 Feb 16;18(1):50. doi: 10.1186/s13075-016-0951-z. PMID: 26883119  

Ciccia F, Guggino G, Ferrante A, Raimondo S, Bignone R, Rodolico V, Peralta S, Van Tok M, Cannizzaro A, Schinocca C, Ruscitti P, Cipriani P, Giacomelli R, Alessandro R, Dieli F, Rizzo A, Baeten D, Triolo G.

IL-9 over-expression and Th9 polarization characterize the inflamed gut, the synovial tissue and the peripheral blood of patients with psoriatic arthritis.

Arthritis Rheumatol. 2016 Feb 19. doi: 10.1002/art.39649. [Epub ahead of print] PMID: 26895441

Cooper C, Bardin T, Brandi ML, Cacoub P, Caminis J, Civitelli R, Cutolo M, Dere W, Devogelaer JP, Diez-Perez A, Einhorn TA, Emonts P, Ethgen O, Kanis JA, Kaufman JM, Kvien TK, Lems WF, McCloskey E, Miossec P, Reiter S, Ringe J, Rizzoli R, Saag K, Reginster JY.

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Aging Clin Exp Res. 2016 Feb;28(1):1-16. doi: 10.1007/s40520-015-0522-1. Epub 2016 Jan 8. PMID: 26746234

De Jong TD, Vosslamber S, Mantel E, de Ridder S, Wesseling JG, van der Pouw Kraan TC, Leurs C, Hegen H, Deisenhammer F, Killestein J, Lundberg IE, Vencovsky J, Nurmohamed MT, van Schaardenburg D, Bultink IE, Voskuyl AE, Pegtel DM, van der Laken CJ, Bijlsma JW, Verweij CL.

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.

Arthritis Res Ther. 2016 Feb 17;18(1):49. doi: 10.1186/s13075-016-0946-9. PMID: 26882897

Hanly JG, O’Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarcón GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V.

The frequency and outcome of lupus nephritis: results from an international inception cohort study.

Rheumatology (Oxford). 2016 Feb;55(2):252-62. doi: 10.1093/rheumatology/kev311. Epub 2015 Sep 5. PMID: 26342222

Kastbom A, Forslind K, Ernestam S, Geborek P, Karlsson JA, Petersson IF, Saevarsdottir S, Klareskog L, van Vollenhoven RF, Lundberg K.

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.

Ann Rheum Dis. 2016 Feb;75(2):356-61. doi: 10.1136/annrheumdis-2014-205698. Epub 2014 Dec 30. PMID: 25550338

Konijn NP, van Tuyl LH, Boers M, den Uyl D, Ter Wee MM, Kerstens P, Voskuyl AE, Nurmohamed M, van Schaardenburg D, Lems WF.

Effective Treatment for Rapid Improvement of Both Disease Activity and Self-Reported Physical Activity in Early Rheumatoid Arthritis.

Arthritis Care Res (Hoboken). 2016 Feb;68(2):280-4. doi: 10.1002/acr.22668. PMID: 26214269

Merrill JT, van Vollenhoven RF, Buyon JP, Furie RA, Stohl W, Morgan-Cox M, Dickson C, Anderson PW, Lee C, Berclaz PY, Dörner T.

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Ann Rheum Dis. 2016 Feb;75(2):332-40. doi: 10.1136/annrheumdis-2015-207654. Epub 2015 Aug 20. PMID: 26293163

Moghadam MG, Vonkeman HE, Ten Klooster PM, Tekstra J, van Schaardenburg D, Starmans-Kool M, Brouwer E, Bos R, Lems WF, Colin EM, Allaart CF, Meek IL, Landewé R, Bernelot Moens HJ, van Riel PL, van de Laar MA, Jansen TL; Dutch National POET Collaboration.

Stopping Tumor Necrosis Factor-inhibitors in Patients with Established Rheumatoid Arthritis in Remission or Stable Low Disease Activity: A Pragmatic Randomized Multicenter Open-Label Controlled Trial.

Arthritis Rheumatol. 2016 Feb 11. doi: 10.1002/art.39626. [Epub ahead of print] PMID: 26866428

Pathak JL, Bakker AD, Luyten FP, Verschueren P, Lems WF, Klein-Nulend J, Bravenboer N.

Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression.

Calcif Tissue Int. 2016 Feb 18. [Epub ahead of print] PMID: 26887974

Sanchez-Ramirez DC, Malfait B, Baert I, van der Leeden M, van Dieën J, Lems WF, Dekker J, Luyten FP, Verschueren S.

Biomechanical and neuromuscular adaptations during the landing phase of a stepping-down task in patients with early or established knee osteoarthritis.

Knee. 2016 Feb 24. pii: S0968-0160(16)00043-0. doi: 10.1016/j.knee.2016.02.002. [Epub ahead of print] PMID: 26922798

Sepriano A, Landewé R, van der Heijde D, Sieper J, Akkoc N, Brandt J, Braun J, Collantes-Estevez E, Dougados M, Fitzgerald O, Huang F, Gu J, Kirazli Y, Maksymowych WP, Marzo-Ortega H, Olivieri I, Ozgocmen S, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Van den Bosch F, van der Horst-Bruinsma I, Weber U, Wei J, Rudwaleit M; ASAS.

Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis.

Ann Rheum Dis. 2016 Feb 10. pii: annrheumdis-2015-208730. doi: 10.1136/annrheumdis-2015-208730. [Epub ahead of print] PMID: 26865599

Strand V, van Vollenhoven RF, Lee EB, Fleischmann R, Zwillich SH, Gruben D, Koncz T, Wilkinson B, Wallenstein G.

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis.

Rheumatology (Oxford). 2016 Feb 29. pii: kev442. [Epub ahead of print] PMID: 26929445

Tas SW, Maracle CX, Balogh E, Szekanecz Z.

Targeting of proangiogenic signalling pathways in chronic inflammation.

Nat Rev Rheumatol. 2016 Feb;12(2):111-22. doi: 10.1038/nrrheum.2015.164. Epub 2015 Dec 3. Review PMID: 26633288

Tas SW, Baeten DL.

Recent Advances in the Treatment of Immune-Mediated Inflammatory Diseases.

Methods Mol Biol. 2016;1371:143-55. doi: 10.1007/978-1-4939-3139-2_9. PMID: 26530799

van Schouwenburg PA, Kruithof S, Wolbink G, Wouters D, Rispens T.

Using monoclonal antibodies as an international standard for the measurement of anti-adalimumab antibodies.

J Pharm Biomed Anal. 2016 Feb 20;120:198-201. doi: 10.1016/j.jpba.2015.12.040. Epub 2015 Dec 28. PMID: 26748377

van Weely SF, Kneepkens EL, Nurmohamed MT, Dekker J, van der Horst-Bruinsma IE.

Continuous improvement of physical functioning in Ankylosing Spondylitis patients by TNF inhibitors: 3-year follow-up and predictors.

Arthritis Care Res (Hoboken). 2016 Feb 16. doi: 10.1002/acr.22869. [Epub ahead of print] PMID: 26881893

Verbrugge SE, Al M, Assaraf YG, Kammerer S, Chandrupatla DM, Honeywell R, Musters RP, Giovannetti E, O’Toole T, Scheffer GL, Krige D, de Gruijl TD, Niessen HW, Lems WF, Kramer PA, Scheper RJ, Cloos J, Ossenkoppele GJ, Peters GJ, Jansen G.

Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR.

Oncotarget. 2016 Feb 2;7(5):5240-57. doi: 10.18632/oncotarget.6169. PMID: 26496029

January 2016

Helliwell T, Brouwer E, Pease CT, Hughes R, Hill CL, Neill LM, Halls S, Simon LS, Mallen CD, Boers M, Kirwan JR, Mackie SL.

Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group.

J Rheumatol. 2016 Jan;43(1):182-6. doi: 10.3899/jrheum.141179. Epub 2015 Nov 15.PMID:26568595

Genovese MC, van Vollenhoven RF, Pacheco-Tena C, Zhang Y, Kinnman N.

VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis.

Arthritis Rheumatol. 2016 Jan;68(1):46-55. doi: 10.1002/art.39473. PMID: 26473751

Karlson EW, van Schaardenburg D, van der Helm-van Mil AH.

Strategies to predict rheumatoid arthritis development in at-risk populations.

Rheumatology (Oxford). 2016 Jan;55(1):6-15. doi: 10.1093/rheumatology/keu287. Epub 2014 Aug 4. Review. PMID: 25096602

Kievit W, van Herwaarden N, van den Hoogen FH, van Vollenhoven RF, Bijlsma JW, van den Bemt BJ, van der Maas A, den Broeder AA.

Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study.

Ann Rheum Dis. 2016 Jan 13. pii: annrheumdis-2015-208317. doi: 10.1136/annrheumdis-2015-208317. [Epub ahead of print] PMID: 26764260

Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG, Sieper J, Baraliakos X, Bennett A, Braun J, Burgos-Vargas R, Dougados M, Pedersen SJ, Jurik AG, Maksymowych WP, Marzo-Ortega H, Østergaard M, Poddubnyy D, Reijnierse M, van den Bosch F, van der Horst-Bruinsma I, Landewé R.

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group.

Ann Rheum Dis. 2016 Jan 14. pii: annrheumdis-2015-208642. doi: 10.1136/annrheumdis-2015-208642. [Epub ahead of print] PMID: 26768408

Marsman AF, Kneepkens EL, Ruwaard J, Wei JC, Nurmohamed MT, van Denderen C, van der Horst-Bruinsma IE, Rispens T, Wolbink G.

Search for a concentration-effect curve of adalimumab in ankylosing spondylitis patients.

Scand J Rheumatol. 2016 Jan 4:1-3. [Epub ahead of print] No abstract available. PMID: 26727457

Reiter-Niesert S, Boers M, Detert J.

Short-term placebo response in trials of patients with symptomatic osteoarthritis: differences between hip and knee.

Osteoarthritis Cartilage. 2016 Jan 14. pii: S1063-4584(16)00008-X. doi: 10.1016/j.joca.2016.01.002. [Epub ahead of print] PMID: 26774732

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

Performance of classification criteria for gout in early and established disease.

Ann Rheum Dis. 2016 Jan;75(1):178-82. doi: 10.1136/annrheumdis-2014-206364. Epub 2014 Oct 28. PMID: 25351521

Ter Wee MM, van Tuyl LH, Blomjous BS, Lems WF, Boers M, Terwee CB.

Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis.

Arthritis Res Ther. 2016 Jan 22;18(1):22. doi: 10.1186/s13075-015-0911-z. PMID: 26794406

van der Linden S, Boonen A, van Tubergen A, Vosse D, Dekker J, Dijkmans B, van der Horst-Bruinsma I, Kapinga T, van der Leeden M, van den Ende C, Hazes JM, Linssen A, Vliet Vlieland T.

Implementation of recommended non-pharmacotherapy in rheumatology practice: need for improvement.

Clin Exp Rheumatol. 2016 Jan-Feb;34(1 Suppl 95):S15-7. Epub 2015 Aug 27. No abstract available. PMID: 26316176

van Tuyl LH, Sadlonova M, Davis B, Flurey C, Goel N, Hewlett SE, Hill CL, Hoogland W, Kirwan JR, van Schaardenburg D, Scholte-Voshaar M, Smolen JS, Stamm T, Wells GA, Boers M.

Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12.

J Rheumatol. 2016 Jan;43(1):203-7. doi: 10.3899/jrheum.141113. Epub 2015 Feb 15. PMID: 25684772

van Vilsteren M, Boot CR, Voskuyl AE, Steenbeek R, van Schaardenburg D, Anema JR.

Process Evaluation of a Workplace Integrated Care Intervention for Workers with Rheumatoid Arthritis.

J Occup Rehabil. 2016 Jan 25. [Epub ahead of print] PMID: 26811171

van Vollenhoven RF, Østergaard M, Leirisalo-Repo M, Uhlig T, Jansson M, Larsson E, Brock F, Franck-Larsson K.

Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis.

Ann Rheum Dis. 2016 Jan;75(1):52-8. doi: 10.1136/annrheumdis-2014-205726. Epub 2015 Apr 14. PMID: 25873634